???global.info.a_carregar???
Markus Maeurer is a Medical Doctor with a Ph.D. by the Johannes Guttenberg University of Mainz (Mainz, Germany). He has been working in several fields, with the main emphasis to the tuberculosis development of novel treatments and/or prevention, host-pathogen interactions, immunotherapy, and the development of new anti-tumoral treatments. During his career, he worked in several institutions, including Johannes Guttenberg University of Mainz (Mainz, Germany), University of Pittsburgh (Pittsburgh, USA), Karolinska Institute (Stockholm, Sweeden) and, currently, as the Head of the ImmunoSurgery/ImmunoTherapy Laboratory at the Champalimaud Center for the Unknown (Lisbon, Portugal). He has over 2 decades of experience in the immunology field and is an expert in the use of immunotherapy to develop new anti-tumoral treatments.
Read full resume ↓
Identification

Personal identification

Full name
Markus Maeurer

Citation names

  • Maeurer, Markus

Author identifiers

Ciência ID
5F10-6C6D-1928
ORCID iD
0000-0002-8436-8077

Addresses

  • Champalimaud Center for the Unknown, Avenida Brasília, 1400-038, Lisbon, Lisbon, Portugal (Professional)

Knowledge fields

  • Medical and Health Sciences - Basic Medicine - Immunology
  • Natural sciences - Biological Sciences - Microbiology

Languages

Language Speaking Reading Writing Listening Peer-review
German (Mother tongue)
English Proficiency (C2) Proficiency (C2) Proficiency (C2) Proficiency (C2) Proficiency (C2)
Portuguese Intermediate (B1) Intermediate (B1) Elementary (A2) Intermediate (B1) Intermediate (B1)
Education
Degree Classification
1987 - 1991
Concluded
 PhD degree (Doktor (PhD))
Johannes Gutenberg Universitat Universitätsmedizin Universitäts-Augenklinik Mainz, Germany
"Role of the first component of complement, C1q, in autoimmunity" (THESIS/DISSERTATION)
1983 - 1989
Concluded
 Medizin (Docteur)
Johannes Gutenberg Universitat Universitätsmedizin Universitäts-Augenklinik Mainz, Germany
Affiliation

Science

Category
Host institution 		Employer
2018 - Current Principal Investigator (Research) Fundação Champalimaud, Portugal
Fundação Champalimaud, Portugal
2012 - 2017 Principal Investigator (Research) Karolinska Institutet, Sweden
Karolinska Institutet, Sweden
1995 - 1997 Principal Investigator (Research) Johannes Gutenberg Universität Institut für Medizinische Mikrobiologie und Hygiene, Germany
Department of Microbiology of the University of Mainz, Germany
1992 - 1993 Postdoc (Research) University of Pittsburgh Department of Surgery, United States
University of Pittsburgh Department of Surgery, United States

Teaching in Higher Education

Category
Host institution 		Employer
1999 - Current Full Professor (University Teacher) Johannes Gutenberg Universität Institut für Medizinische Mikrobiologie und Hygiene, Germany
Johannes Gutenberg Universität Institut für Medizinische Mikrobiologie und Hygiene, Germany
2005 - 2012 Full Professor (University Teacher) Johannes Gutenberg Universität Institut für Medizinische Mikrobiologie und Hygiene, Germany
Johannes Gutenberg Universität Institut für Medizinische Mikrobiologie und Hygiene, Germany
1998 - 1999 Assistant Professor (University Teacher) Johannes Gutenberg Universität Institut für Medizinische Mikrobiologie und Hygiene, Germany
Johannes Gutenberg Universität Institut für Medizinische Mikrobiologie und Hygiene, Germany
1994 - 1995 Assistant Professor (University Teacher) University of Pittsburgh Department of Surgery, United States
University of Pittsburgh Department of Surgery, United States
1989 - 1992 Associate Professor (University Teacher) Johannes Gutenberg Universität Institut für Medizinische Mikrobiologie und Hygiene, Germany
Department of Microbiology of the University of Mainz, Germany

Other Careers

Category
Host institution 		Employer
1995 - 1997 Assistente graduado sénior (Médica) Johannes Gutenberg Universität Institut für Medizinische Mikrobiologie und Hygiene, Germany
Johannes Gutenberg Universität Mainz Medizinische Klinik II Kardiologie Angiologie und Internistische Intensivmedizin, Germany

Positions / Appointments

Category
Host institution 		Employer
2000 - 2004 Vice-President Johannes Gutenberg Universität Institut für Medizinische Mikrobiologie und Hygiene, Germany
Johannes Gutenberg Universität Institut für Medizinische Mikrobiologie und Hygiene, Germany
Projects

Grant

Designation Funders
2019/01/01 - 2020/12/31 FCImuno - Valorization and Technology Transfer Center in Immunotherapy of the Fundação D. Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud
LISBOA-01-0246-FEDER-000007
Principal investigator
Fundação Champalimaud, Portugal
Ongoing
2000/01/01 - 2005/12/31 Immunological control of infections with mycobacterium
5483829
Principal investigator
Johannes Gutenberg Universität Institut für Medizinische Mikrobiologie und Hygiene, Germany
 Deutsche Forschungsgemeinschaft
Concluded
1996/01/01 - 2005/12/31 Mechanistic and immunological studies on the role of HPV16 and HPV18 E6/7 mutations in cervical cancer and its precursors
5480425
Principal investigator
Johannes Gutenberg Universität Institut für Medizinische Mikrobiologie und Hygiene, Germany
 Deutsche Forschungsgemeinschaft
Concluded
2001 - 2004 Production of transgenic T cells
111
Principal investigator
Johannes Gutenberg Universitat Mainz Institut für Mikrobiologie und Weinforschung, Germany
 Stiftung Rheinland-Pfalz für Innovation
Concluded
Outputs

Publications

Book
  1. Gaseitsiwe, S.; Maeurer, M.J.. Identification of mhc class ii binding peptides: Microarray and soluble mhc class ii molecules. 2009.
    10.1007/978-1-59745-450-6_30
  2. Ahmed, R.K.S.; Maeurer, M.J.. T-cell epitope mapping. 2009.
    10.1007/978-1-59745-450-6_31
  3. Maeurer, M.J.. TCR analyses: T-cell receptor CDR3 analysis: Molecular fingerprinting of the T-cell receptor repertoire. 2005.
    10.1007/1-4020-3623-X_14
  4. Castelli, C.; Maeurer, M.J.. The T-cell response in patients with cancer. 2002.
    10.1016/S0065-230X(02)86005-5
Book chapter
  1. Ligeiro, D.; Rao, M.; Maia, A.; Castillo, M.; Beltran, A.; Maeurer, M.. "B Cells in the Gastrointestinal Tumor Microenvironment with a Focus on Pancreatic Cancer: Opportunities for Precision Medicine?". 175-195. 2020.
    10.1007/978-3-030-49270-0_10
  2. Maeurer, Markus. "Mutant Epitopes in Cancer". 2018.
    10.1007/978-3-319-62431-0_4
  3. TRINDER, P; MAEURER, M; Trinder, P.K.E.; Maeurer, M.J.. "Interleukin-7". In The Cytokine Handbook, 305-345. Elsevier, 2003.
    10.1016/b978-012689663-3/50017-x
  4. Maeurer, Markus. "New Avenues of Cancer Treatment: Modulation of Host Antitumor Directed Immune Responses by IL-4 and IL-12 in Renal Cell Cancer". 1995.
    10.1007/978-1-4612-2536-2_15
Journal article
  1. Petersen E; Al-Abri S; Chakaya J; Goletti D; Parolina L; Wejse C; Mucheleng'anga LA; et al. "World TB Day 2022: Revamping and Reshaping Global TB Control Programs by Advancing Lessons learnt from the COVID-19 pandemic.". International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases (2022): http://europepmc.org/abstract/med/35248715.
    10.1016/j.ijid.2022.02.057
  2. "Blue Skies research is essential for ending the Tuberculosis pandemic and advancing a personalized medicine approach for holistic management of Respiratory Tract infections.". International Journal of Infectious Diseases (2022): http://dx.doi.org/10.1016/j.ijid.2022.03.012.
    10.1016/j.ijid.2022.03.012
  3. "The WHO Global Tuberculosis 2021 Report – not so good news and turning the tide back to End TB". International Journal of Infectious Diseases (2022): http://dx.doi.org/10.1016/j.ijid.2022.03.011.
    10.1016/j.ijid.2022.03.011
  4. Fahrner JE; Lahmar I; Goubet AG; Haddad Y; Carrier A; Mazzenga M; Drubay D; et al. "The polarity and specificity of antiviral T lymphocyte responses determine susceptibility to SARS-CoV-2 infection in cancer patients and healthy individuals.". Cancer discovery (2022): http://europepmc.org/abstract/med/35179201.
    10.1158/2159-8290.cd-21-1441
  5. Petersen, E.; Ntoumi, F.; Hui, D.S.; Abubakar, A.; Kramer, L.D.; Obiero, C.; Tambyah, P.A.; et al. "Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts". International Journal of Infectious Diseases 114 (2022): 268-272. http://www.scopus.com/inward/record.url?eid=2-s2.0-85120980079&partnerID=MN8TOARS.
    10.1016/j.ijid.2021.11.040
  6. Lanini, S.; Capone, S.; Antinori, A.; Milleri, S.; Nicastri, E.; Camerini, R.; Agrati, C.; et al. "GRAd-COV2, a gorilla adenovirus-based candidate vaccine against COVID-19, is safe and immunogenic in younger and older adults". Science Translational Medicine 14 627 (2022): http://www.scopus.com/inward/record.url?eid=2-s2.0-85123530389&partnerID=MN8TOARS.
    10.1126/scitranslmed.abj1996
  7. Timothy D. Shaw; Anna D. Krasnodembskaya; Gunnar N. Schroeder; Alimuddin Zumla; Markus Maeurer; Cecilia M. O’Kane. "Mesenchymal Stromal Cells: an Antimicrobial and Host-Directed Therapy for Complex Infectious Diseases". Clinical Microbiology Reviews 34 4 (2021): https://doi.org/10.1128/CMR.00064-21.
    10.1128/CMR.00064-21
  8. Goubet, A.-G.; Dubuisson, A.; Geraud, A.; Danlos, F.-X.; Terrisse, S.; Silva, C.A.C.; Drubay, D.; et al. "Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis". Cell Death and Differentiation 28 12 (2021): 3297-3315. http://www.scopus.com/inward/record.url?eid=2-s2.0-85109954877&partnerID=MN8TOARS.
    10.1038/s41418-021-00817-9
  9. Nagu, T.J.; Mboka, M.A.; Nkrumbih, Z.F.; Shayo, G.; Mizinduko, M.M.; Komba, E.V.; Maeurer, M.; Zumla, A.; Mugusi, F.. "Clinical and Imaging Features of Adults with Recurrent Pulmonary Tuberculosis - A Prospective Case-Controlled Study". International Journal of Infectious Diseases 113 (2021): S33-S39. http://www.scopus.com/inward/record.url?eid=2-s2.0-85103067532&partnerID=MN8TOARS.
    10.1016/j.ijid.2021.01.071
  10. Singh, J.; Alam, A.; Samal, J.; Maeurer, M.; Ehtesham, N.Z.; Chakaya, J.; Hira, S.; Hasnain, S.E.. "Role of multiple factors likely contributing to severity-mortality of COVID-19". Infection, Genetics and Evolution 96 (2021): http://www.scopus.com/inward/record.url?eid=2-s2.0-85118511481&partnerID=MN8TOARS.
    10.1016/j.meegid.2021.105101
  11. Bordoni, V.; Tartaglia, E.; Sacchi, A.; Fimia, G.M.; Cimini, E.; Casetti, R.; Notari, S.; et al. "The unbalanced p53/SIRT1 axis may impact lymphocyte homeostasis in COVID-19 patients". International Journal of Infectious Diseases 105 (2021): 49-53. http://www.scopus.com/inward/record.url?eid=2-s2.0-85101825288&partnerID=MN8TOARS.
    10.1016/j.ijid.2021.02.019
  12. Shi, L.; Huang, H.; Lu, X.; Yan, X.; Jiang, X.; Xu, R.; Wang, S.; et al. "Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial". Signal Transduction and Targeted Therapy 6 1 (2021): http://www.scopus.com/inward/record.url?eid=2-s2.0-85101121909&partnerID=MN8TOARS.
    10.1038/s41392-021-00488-5
  13. Nachega, J.B.; Maeurer, M.; Sam-Agudu, N.A.; Chakaya, J.; Katoto, P.D.M.; Zumla, A.. "Bacille Calmette-Guérin (BCG) vaccine and potential cross-protection against SARS-CoV-2 infection — Assumptions, knowns, unknowns and need for developing an accurate scientific evidence base". International Journal of Infectious Diseases 113 (2021): S78-S81. http://www.scopus.com/inward/record.url?eid=2-s2.0-85104129068&partnerID=MN8TOARS.
    10.1016/j.ijid.2021.03.060
  14. de Sousa, E.; Lérias, J.R.; Beltran, A.; Paraschoudi, G.; Condeço, C.; Kamiki, J.; António, P.A.; et al. "Targeting Neoepitopes to Treat Solid Malignancies: Immunosurgery". Frontiers in Immunology 12 (2021): http://www.scopus.com/inward/record.url?eid=2-s2.0-85111760595&partnerID=MN8TOARS.
    10.3389/fimmu.2021.592031
  15. Zumla, A.; Chakaya, J.; Khan, M.; Fatima, R.; Wejse, C.; Al-Abri, S.; Fox, G.J.; et al. "World Tuberculosis Day 2021 Theme — ‘The Clock is Ticking’ — and the world is running out of time to deliver the United Nations General Assembly commitments to End TB due to the COVID-19 pandemic". International Journal of Infectious Diseases 113 (2021): S1-S6. http://www.scopus.com/inward/record.url?eid=2-s2.0-85103123168&partnerID=MN8TOARS.
    10.1016/j.ijid.2021.03.046
  16. Maeurer, M.; Ramalho, R.; Wang, F.-S.; Zumla, A.. "Host-directed therapies for COVID-19". Current opinion in pulmonary medicine 27 3 (2021): 205-209. http://www.scopus.com/inward/record.url?eid=2-s2.0-85103683596&partnerID=MN8TOARS.
    10.1097/MCP.0000000000000769
  17. Messina, F.; Giombini, E.; Montaldo, C.; Sharma, A.A.; Zoccoli, A.; Sekaly, R.-P.; Locatelli, F.; et al. "Looking for pathways related to COVID-19: confirmation of pathogenic mechanisms by SARS-CoV-2–host interactome". Cell Death and Disease 12 8 (2021): http://www.scopus.com/inward/record.url?eid=2-s2.0-85111040351&partnerID=MN8TOARS.
    10.1038/s41419-021-03881-8
  18. Ippolito G; Lauria FN; Locatelli F; Magrini N; Montaldo C; Sadun R; Maeurer M; et al. "Lessons from the COVID-19 Pandemic-Unique Opportunities for Unifying, Revamping and Reshaping Epidemic Preparedness of Europe's Public Health Systems.". International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases (2020): http://europepmc.org/abstract/med/33152511.
    10.1016/j.ijid.2020.10.094
  19. Sacchi A; Grassi G; Bordoni V; Lorenzini P; Cimini E; Casetti R; Tartaglia E; et al. "Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome.". Cell death & disease (2020): http://europepmc.org/abstract/med/33110074.
    10.1038/s41419-020-03125-1
  20. Mondi A; Cimini E; Colavita F; Cicalini S; Pinnetti C; Matusali G; Casetti R; et al. "COVID-19 in people living with HIV: Clinical implications of dynamics of the immune response to SARS-CoV-2.". Journal of medical virology (2020): http://europepmc.org/abstract/med/32975842.
    10.1002/jmv.26556
  21. Zhang JY; Wang XM; Xing X; Xu Z; Zhang C; Song JW; Fan X; et al. "Single-cell landscape of immunological responses in patients with COVID-19.". Nature immunology (2020): http://europepmc.org/abstract/med/32788748.
    10.1038/s41590-020-0762-x
  22. Zumla A; Marais BJ; McHugh TD; Maeurer M; Kapata N; Ntoumi F; Chanda-Kapata P; et al. "COVID-19 and tuberculosis-threats and opportunities.". The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease (2020): http://europepmc.org/abstract/med/32912377.
    10.5588/ijtld.20.0387
  23. Melenotte C; Silvin A; Goubet AG; Lahmar I; Dubuisson A; Zumla A; Raoult D; et al. "Immune responses during COVID-19 infection.". Oncoimmunology (2020): http://europepmc.org/abstract/med/32939324.
    10.1080/2162402x.2020.1807836
  24. Meng F; Xu R; Wang S; Xu Z; Zhang C; Li Y; Yang T; et al. "Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial.". Signal transduction and targeted therapy (2020): http://europepmc.org/abstract/med/32855385.
    10.1038/s41392-020-00286-5
  25. de Sousa E; Ligeiro D; Lérias JR; Zhang C; Agrati C; Osman M; El-Kafrawy SA; et al. "Mortality in COVID-19 disease patients: Correlating the association of major histocompatibility complex (MHC) with severe acute respiratory syndrome 2 (SARS-CoV-2) variants.". International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases (2020): http://europepmc.org/abstract/med/32693089.
    10.1016/j.ijid.2020.07.016
  26. Song JW; Zhang C; Fan X; Meng FP; Xu Z; Xia P; Cao WJ; et al. "Immunological and inflammatory profiles in mild and severe cases of COVID-19.". Nature communications (2020): http://europepmc.org/abstract/med/32641700.
    10.1038/s41467-020-17240-2
  27. Agrati C; Sacchi A; Bordoni V; Cimini E; Notari S; Grassi G; Casetti R; et al. "Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19).". Cell death and differentiation (2020): http://europepmc.org/abstract/med/32514047.
    10.1038/s41418-020-0572-6
  28. Ramalho R; Rao M; Zhang C; Agrati C; Ippolito G; Wang FS; Zumla A; Maeurer M. "Immunometabolism: new insights and lessons from antigen-directed cellular immune responses.". Seminars in immunopathology (2020): http://europepmc.org/abstract/med/32519148.
    10.1007/s00281-020-00798-w
  29. Messina F; Giombini E; Agrati C; Vairo F; Ascoli Bartoli T; Al Moghazi S; Piacentini M; et al. "COVID-19: viral-host interactome analyzed by network based-approach model to study pathogenesis of SARS-CoV-2 infection.". Journal of translational medicine (2020): http://europepmc.org/abstract/med/32522207.
    10.1186/s12967-020-02405-w
  30. Zumla A; Wang FS; Ippolito G; Petrosillo N; Agrati C; Azhar EI; Chang C; et al. "Reducing mortality and morbidity in patients with severe COVID-19 disease by advancing ongoing trials of Mesenchymal Stromal (stem) Cell (MSC) therapy - Achieving global consensus and visibility for cellular host-directed therapies.". International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases (2020): http://europepmc.org/abstract/med/32425638.
    10.1016/j.ijid.2020.05.040
  31. Bordoni V; Sacchi A; Cimini E; Notari S; Grassi G; Tartaglia E; Casetti R; et al. "An inflammatory profile correlates with decreased frequency of cytotoxic cells in COVID-19.". Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2020): http://europepmc.org/abstract/med/32407466.
    10.1093/cid/ciaa577
  32. Akkerman, Onno W.; ter Beek, Lies; Centis, Rosella; Maeurer, Markus; Visca, Dina; Muñoz-Torrico, Marcela; Tiberi, Simon; Migliori, Giovanni Battista. "Rehabilitation, optimized nutritional care, and boosting host internal milieu to improve long-term treatment outcomes in tuberculosis patients". International Journal of Infectious Diseases 92 (2020): S10-S14. http://dx.doi.org/10.1016/j.ijid.2020.01.029.
    10.1016/j.ijid.2020.01.029
  33. Tiberi S; Migliori GB; Muhwa Chakaya J; Kaesava T; Al Abri SS; Wejse C; Goletti D; et al. "Commemorating World TB Day 2020: "IT'S TIME" - It's time to End the Global TB Epidemic.". International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases (2020): http://europepmc.org/abstract/med/32145464.
    10.1016/j.ijid.2020.03.001
  34. Zumla, Alimuddin; Hui, David S; Azhar, Esam I; Memish, Ziad A; Maeurer, Markus; Zumla, A.; Hui, D.S.; et al. "Reducing mortality from 2019-nCoV: host-directed therapies should be an option". The Lancet 395 10224 (2020): e35-e36. http://dx.doi.org/10.1016/s0140-6736(20)30305-6.
    10.1016/s0140-6736(20)30305-6
  35. Ippolito G; Hui DS; Ntoumi F; Maeurer M; Zumla A. "Toning down the 2019-nCoV media hype-and restoring hope.". The Lancet. Respiratory Medicine (2020): http://europepmc.org/abstract/med/32146924.
    10.1016/S2213-2600(20)30070-9
  36. Lérias, Joana R.; Paraschoudi, Georgia; de Sousa, Eric; Martins, João; Condeço, Carolina; Figueiredo, Nuno; Carvalho, Carlos; et al. "Microbes as Master Immunomodulators: Immunopathology, Cancer and Personalized Immunotherapies". Frontiers in Cell and Developmental Biology 7 (2020): http://dx.doi.org/10.3389/fcell.2019.00362.
    10.3389/fcell.2019.00362
  37. Lérias, Joana R.; de Sousa, Eric; Paraschoudi, Georgia; Martins, João; Condeço, Carolina; Figueiredo, Nuno; Carvalho, Carlos; et al. "Trained Immunity for Personalized Cancer Immunotherapy: Current Knowledge and Future Opportunities". Frontiers in Microbiology 10 (2020): http://dx.doi.org/10.3389/fmicb.2019.02924.
    10.3389/fmicb.2019.02924
  38. Zumla, A.; Ippolito, G.; Ntoumi, F.; Seyfert-Margolies, V.; Nagu, T.J.; Cirillo, D.; Chakaya, J.M.; et al. "Host-directed therapies and holistic care for tuberculosis". The Lancet Respiratory Medicine 8 4 (2020): 337-340. http://www.scopus.com/inward/record.url?eid=2-s2.0-85082517916&partnerID=MN8TOARS.
    10.1016/S2213-2600(20)30078-3
  39. Carsetti, R.; Zaffina, S.; Piano Mortari, E.; Terreri, S.; Corrente, F.; Capponi, C.; Palomba, P.; et al. "Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases". Frontiers in Immunology 11 (2020): http://www.scopus.com/inward/record.url?eid=2-s2.0-85098483603&partnerID=MN8TOARS.
    10.3389/fimmu.2020.610300
  40. Lanini, S.; Montaldo, C.; Nicastri, E.; Vairo, F.; Agrati, C.; Petrosillo, N.; Scognamiglio, P.; et al. "COVID-19 disease - Temporal analyses of complete blood count parameters over course of illness, and relationship to patient demographics and management outcomes in survivors and non-survivors: A longitudinal descriptive cohort study". PLoS ONE 15 12 Decembe (2020): http://www.scopus.com/inward/record.url?eid=2-s2.0-85098991096&partnerID=MN8TOARS.
    10.1371/journal.pone.0244129
  41. Khader, Shabaana A.; Divangahi, Maziar; Hanekom, Willem; Hill, Philip C.; Maeurer, Markus; Makar, Karen W.; Mayer-Barber, Katrin D.; et al. "Targeting innate immunity for tuberculosis vaccination". Journal of Clinical Investigation 129 9 (2019): 3482-3491. http://dx.doi.org/10.1172/jci128877.
    10.1172/jci128877
  42. Rao, Martin; Dodoo, Ernest; Zumla, Alimuddin; Maeurer, Markus. "Immunometabolism and Pulmonary Infections: Implications for Protective Immune Responses and Host-Directed Therapies". Frontiers in Microbiology 10 (2019): http://dx.doi.org/10.3389/fmicb.2019.00962.
    10.3389/fmicb.2019.00962
  43. Abubakar I; Chakaya J; Maeurer M; Zumla A; Abubakar, I.; Chakaya, J.; Maeurer, M.; Zumla, A.. "Towards optimal treatment for latent Mycobacterium tuberculosis infection.". The Lancet. Respiratory Medicine 7 3 (2019): 195-197. http://europepmc.org/abstract/med/30823969.
    10.1016/s2213-2600(19)30036-0
  44. Petersen E; Rao M; Ippolito G; Gualano G; Chakaya J; Ntoumi F; Moore D; et al. "World Tuberculosis Day March 24th 2019 Theme: "It's TIME" - International Journal of Infectious Diseases Tuberculosis Theme Series.". International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases (2019): http://europepmc.org/abstract/med/30802624.
    10.1016/j.ijid.2019.02.024
  45. Sinclair G; Benmakhlouf H; Martin H; Maeurer M; Dodoo E. "Adaptive hypofractionated gamma knife radiosurgery in the acute management of brainstem metastases.". Surgical Neurology International (2019): http://europepmc.org/abstract/med/30783544.
    10.4103/sni.sni_53_18
  46. Martin Rao; Giuseppe Ippolito; Sayoki Mfinanga; Francine Ntoumi; Dorothy Yeboah-Manu; Cristina Vilaplana; Alimuddin Zumla; et al. "Latent TB Infection (LTBI) - Mycobacterium tuberculosis pathogenesis and the dynamics of the granuloma battleground". International Journal of Infectious Diseases 80 (2019): S58-S61. http://dx.doi.org/10.1016/j.ijid.2019.02.035.
    10.1016/j.ijid.2019.02.035
  47. Martin Rao; Giuseppe Ippolito; Sayoki Mfinanga; Francine Ntoumi; Dorothy Yeboah-Manu; Cris Vilaplana; Alimuddin Zumla; et al. "Improving treatment outcomes for MDR-TB — novel host-directed therapies and personalised medicine of the future". International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases (2019): http://europepmc.org/abstract/med/30685590.
    10.1016/j.ijid.2019.01.039
  48. Rao, M.; Ligeiro, D.; Maeurer, M.; Rao, Martin; Ligeiro, Dario; Maeurer, Markus. "Precision medicine in the clinical management of respiratory tract infections including multidrug-resistant tuberculosis: learning from innovations in immuno-oncology". Current opinion in pulmonary medicine 25 3 (2019): 233-241. http://www.scopus.com/inward/record.url?eid=2-s2.0-85063922438&partnerID=MN8TOARS.
    10.1097/MCP.0000000000000575
  49. Joana Le´rias; Georgia Paraschoudi; Ines Silva; Joa~o Martins; Eric de Sousa; Carolina Condec¸o; Nuno Figueiredo; et al. "Clinically relevant immune responses against Cytomegalovirus : implications for precision medicine". (2019):
    10.3390/ijms20081986
  50. Valentini D; Rao M; Meng Q; von Landenberg A; Bartek J; Sinclair G; Paraschoudi G; et al. "Correction: Identification of neoepitopes recognized by tumor-infiltrating lymphocytes (TILs) from patients with glioma.". Oncotarget (2018): http://europepmc.org/abstract/med/30613370.
    10.18632/oncotarget.26447
  51. Meng, Qingda; Valentini, Davide; Rao, Martin; Dodoo, Ernest; Maeurer, Markus. "CMV and EBV targets recognized by tumor-infiltrating B lymphocytes in pancreatic cancer and brain tumors". Scientific Reports 8 1 (2018): http://dx.doi.org/10.1038/s41598-018-34710-2.
    10.1038/s41598-018-34710-2
  52. Meng, Qingda; Valentini, Davide; Rao, Martin; Moro, Carlos Fernández; Paraschoudi, Georgia; Jäger, Elke; Dodoo, Ernest; et al. "Neoepitope targets of tumour-infiltrating lymphocytes from patients with pancreatic cancer". British Journal of Cancer 120 1 (2018): 97-108. http://dx.doi.org/10.1038/s41416-018-0262-z.
    10.1038/s41416-018-0262-z
  53. Meng, Qingda; Valentini, Davide; Rao, Martin; Maeurer, Markus. "KRAS RENAISSANCE(S) in Tumor Infiltrating B Cells in Pancreatic Cancer". Frontiers in Oncology 8 (2018): http://dx.doi.org/10.3389/fonc.2018.00384.
    10.3389/fonc.2018.00384
  54. Luo, Xiao-Hua; Meng, Qingda; Rao, Martin; Liu, Zhenjiang; Paraschoudi, Georgia; Dodoo, Ernest; Maeurer, Markus. "The impact of inflationary cytomegalovirus-specific memory T cells on anti-tumour immune responses in patients with cancer". Immunology 155 3 (2018): 294-308. http://dx.doi.org/10.1111/imm.12991.
    10.1111/imm.12991
  55. Liu, Zhenjiang; Poiret, Thomas; Meng, Qingda; Rao, Martin; von Landenberg, Anna; Schoutrop, Esther; Valentini, Davide; et al. "Epstein–Barr virus- and cytomegalovirus-specific immune response in patients with brain cancer". Journal of Translational Medicine 16 1 (2018): http://dx.doi.org/10.1186/s12967-018-1557-9.
    10.1186/s12967-018-1557-9
  56. Zhenjiang, Liu; Rao, Martin; Luo, Xiaohua; Valentini, Davide; von Landenberg, Anna; Meng, Qingda; Sinclair, Georges; et al. "Cytokine Networks and Survivin Peptide-Specific Cellular Immune Responses Predict Improved Survival in Patients With Glioblastoma Multiforme". EBioMedicine 33 (2018): 49-56. http://dx.doi.org/10.1016/j.ebiom.2018.06.014.
    10.1016/j.ebiom.2018.06.014
  57. Tiberi, Simon; du Plessis, Nelita; Walzl, Gerhard; Vjecha, Michael J; Rao, Martin; Ntoumi, Francine; Mfinanga, Sayoki; et al. "Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies". The Lancet Infectious Diseases 18 7 (2018): e183-e198. http://dx.doi.org/10.1016/s1473-3099(18)30110-5.
    10.1016/s1473-3099(18)30110-5
  58. Nagu TJ; Aboud S; Matee MI; Maeurer MJ; Fawzi WW; Mugusi F. "Effects of isoniazid resistance on TB treatment outcomes under programmatic conditions in a high-TB and -HIV setting: a prospective multicentre study-authors' response.". The Journal of antimicrobial chemotherapy (2018): http://europepmc.org/abstract/med/29635525.
    10.1093/jac/dky104
  59. Sinclair G; Benmakhlouf H; Martin H; Brigui M; Maeurer M; Dodoo E. "The role of radiosurgery in the acute management of fourth ventricle compression due to brain metastases.". Surgical Neurology International (2018): http://europepmc.org/abstract/med/29930878.
    10.4103/sni.sni_387_17
  60. Poiret, Thomas; Axelsson-Robertson, Rebecca; Remberger, Mats; Luo, Xiao-Hua; Rao, Martin; Nagchowdhury, Anurupa; Von Landenberg, Anna; et al. "Cytomegalovirus-Specific CD8+ T-Cells With Different T-Cell Receptor Affinities Segregate T-Cell Phenotypes and Correlate With Chronic Graft-Versus-Host Disease in Patients Post-Hematopoietic Stem Cell Transplantation". Frontiers in Immunology 9 (2018): http://dx.doi.org/10.3389/fimmu.2018.00760.
    10.3389/fimmu.2018.00760
  61. Meng, Qingda; Valentini, Davide; Rao, Martin; Liu, Zhenjiang; Xie, Shanshan; Morgell, Ann; Dodoo, Ernest; et al. "Prediction of improved survival in patients with pancreatic cancer via IL-21 enhanced detection of mesothelin epitope-reactive T-cell responses". Oncotarget 9 32 (2018): http://dx.doi.org/10.18632/oncotarget.25121.
    10.18632/oncotarget.25121
  62. Rao, Martin; Valentini, Davide; Zumla, Alimuddin; Maeurer, Markus. "Evaluation of the efficacy of valproic acid and suberoylanilide hydroxamic acid (vorinostat) in enhancing the effects of first-line tuberculosis drugs against intracellular Mycobacterium tuberculosis". International Journal of Infectious Diseases 69 (2018): 78-84. http://dx.doi.org/10.1016/j.ijid.2018.02.021.
    10.1016/j.ijid.2018.02.021
  63. Maeurer M; Rao M; Zumla A; Maeurer, M.; Rao, M.; Zumla, A.. "B cells or T cells in TB: a continuing conundrum.". The Lancet. Respiratory Medicine 6 4 (2018): 237-238. http://europepmc.org/abstract/med/29595500.
    10.1016/s2213-2600(18)30080-8
  64. Valentini, Davide; Rao, Martin; Meng, Qingda; von Landenberg, Anna; Bartek, Jiri; Sinclair, Georges; Paraschoudi, Georgia; et al. "Identification of neoepitopes recognized by tumor-infiltrating lymphocytes (TILs) from patients with glioma". Oncotarget 9 28 (2018): http://dx.doi.org/10.18632/oncotarget.24955.
    10.18632/oncotarget.24955
  65. Tiberi S; Petersen E; Maeurer M; Ntoumi F; Yeboa-Manu D; Mwaba P; Vilaplana C; et al. "Taking forward the Stop TB Partnership and World Health Organization Joint Theme for World TB Day March 24th 2018 - "Wanted: Leaders for a TB-Free World. You can make history. End TB".". International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases (2018): http://europepmc.org/abstract/med/29571578.
    10.1016/j.ijid.2018.03.002
  66. Kappos L; Bar-Or A; Cree BAC; Fox RJ; Giovannoni G; Gold R; Vermersch P; et al. "Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study.". Lancet (London, England) (2018): http://europepmc.org/abstract/med/29576505.
    10.1016/s0140-6736(18)30475-6
  67. Smith JR; Pe'er J; Belfort RN; Cardoso F; Carvajal RD; Carvalho C; Coupland SE; et al. "Proceedings of the Association for Research in Vision and Ophthalmology and Champalimaud Foundation Ocular Oncogenesis and Oncology Conference.". Translational vision science & technology (2018): http://europepmc.org/abstract/med/30652059.
    10.1167/tvst.8.1.9
  68. Sinclair, Georges; Benmakhlouf, Hamza; Brigui, Marina; Maeurer, Markus; Dodoo, Ernest. "The concept of rapid rescue radiosurgery in the acute management of critically located brain metastases: A retrospective short-term outcome analysis". Surgical Neurology International 9 1 (2018): 218. http://dx.doi.org/10.4103/sni.sni_480_17.
    10.4103/sni.sni_480_17
  69. Liu, Zhenjiang; Poiret, Thomas; Persson, Oscar; Meng, Qingda; Rane, Lalit; Bartek, Jiri; Karbach, Julia; et al. "NY-ESO-1- and survivin-specific T-cell responses in the peripheral blood from patients with glioma". Cancer Immunology, Immunotherapy 67 2 (2017): 237-246. http://dx.doi.org/10.1007/s00262-017-2066-z.
    10.1007/s00262-017-2066-z
  70. Zhenjiang, Liu; Rao, Martin; Luo, Xiaohua; Sandberg, Elisabeth; Bartek, Jiri; Schoutrop, Esther; von Landenberg, Anna; et al. "Mesothelin-specific Immune Responses Predict Survival of Patients With Brain Metastasis". EBioMedicine 23 (2017): 20-24. http://dx.doi.org/10.1016/j.ebiom.2017.08.024.
    10.1016/j.ebiom.2017.08.024
  71. Liu, Zhenjiang; Rao, Martin; Poiret, Thomas; Nava, Silvia; Meng, Qingda; von Landenberg, Anna; Bartek, Jiri; et al. "Mesothelin as a novel biomarker and immunotherapeutic target in human glioblastoma". Oncotarget 8 46 (2017): http://dx.doi.org/10.18632/oncotarget.20303.
    10.18632/oncotarget.20303
  72. Wunsch M; Jabari S; Voussen B; Enders M; Srinivasan S; Cossais F; Wedel T; et al. "The enteric nervous system is a potential autoimmune target in multiple sclerosis.". Acta neuropathologica (2017): http://europepmc.org/abstract/med/28620692.
    10.1007/s00401-017-1742-6
  73. Valentini, D.; Rao, M.; Ferrara, G.; Perkins, M.; Dodoo, E.; Zumla, A.; Maeurer, M.. "Immune recognition surface construction of Mycobacterium tuberculosis epitope-specific antibody responses in tuberculosis patients identified by peptide microarrays". International Journal of Infectious Diseases 56 (2017): 155-166. http://www.scopus.com/inward/record.url?eid=2-s2.0-85013830572&partnerID=MN8TOARS.
    10.1016/j.ijid.2017.01.015
  74. Ferrara, G.; Valentini, D.; Rao, M.; Wahlström, J.; Grunewald, J.; Larsson, L.-O.; Brighenti, S.; et al. "Humoral immune profiling of mycobacterial antigen recognition in sarcoidosis and Löfgren's syndrome using high-content peptide microarrays". International Journal of Infectious Diseases 56 (2017): 167-175. http://www.scopus.com/inward/record.url?eid=2-s2.0-85013372012&partnerID=MN8TOARS.
    10.1016/j.ijid.2017.01.021
  75. Nagu, T.; Aboud, S.; Rao, M.; Matee, M.; Axelsson, R.; Valentini, D.; Mugusi, F.; Zumla, A.; Maeurer, M.. "Strong anti-Epstein Barr virus (EBV) or cytomegalovirus (CMV) cellular immune responses predict survival and a favourable response to anti-tuberculosis therapy". International Journal of Infectious Diseases 56 (2017): 136-139. http://www.scopus.com/inward/record.url?eid=2-s2.0-85013794959&partnerID=MN8TOARS.
    10.1016/j.ijid.2017.01.022
  76. Liu, Z.; Meng, Q.; Bartek, J.; Poiret, T.; Persson, O.; Rane, L.; Rangelova, E.; et al. "Tumor-infiltrating lymphocytes (TILs) from patients with glioma". OncoImmunology 6 2 (2017): e1252894. http://www.scopus.com/inward/record.url?eid=2-s2.0-85011818248&partnerID=MN8TOARS.
    10.1080/2162402X.2016.1252894
  77. Valentini, D.; Rao, M.; Rane, L.; Rahman, S.; Axelsson-Robertson, R.; Heuchel, R.; Löhr, M.; et al. "Peptide microarray-based characterization of antibody responses to host proteins after bacille Calmette–Guérin vaccination". International Journal of Infectious Diseases 56 (2017): 140-154. http://www.scopus.com/inward/record.url?eid=2-s2.0-85014259491&partnerID=MN8TOARS.
    10.1016/j.ijid.2017.01.027
  78. Rao, M.; Valentini, D.; Dodoo, E.; Zumla, A.; Maeurer, M.. "Anti-PD-1/PD-L1 therapy for infectious diseases: learning from the cancer paradigm". International Journal of Infectious Diseases 56 (2017): 221-228. http://www.scopus.com/inward/record.url?eid=2-s2.0-85013411102&partnerID=MN8TOARS.
    10.1016/j.ijid.2017.01.028
  79. Boggiano, C.; Eichelberg, K.; Ramachandra, L.; Shea, J.; Ramakrishnan, L.; Behar, S.; Ernst, J.D.; et al. "“The Impact of Mycobacterium tuberculosis Immune Evasion on Protective Immunity: Implications for TB Vaccine Design” – Meeting report". Vaccine 35 27 (2017): 3433-3440. http://www.scopus.com/inward/record.url?eid=2-s2.0-85018954298&partnerID=MN8TOARS.
    10.1016/j.vaccine.2017.04.007
  80. Rane, L.; Rahman, S.; Magalhaes, I.; Ambati, A.; Andersson, J.; Zumla, A.; Brighenti, S.; Maeurer, M.J.. "IL-7d5 protein is expressed in human tissues and induces expression of the oxidized low density lipoprotein receptor 1 (OLR1) in CD14+ monocytes". International Journal of Infectious Diseases 59 (2017): 29-36. http://www.scopus.com/inward/record.url?eid=2-s2.0-85018492411&partnerID=MN8TOARS.
    10.1016/j.ijid.2017.03.001
  81. Zumla, A.; Otchere, I.D.; Mensah, G.I.; Asante-Poku, A.; Gehre, F.; Maeurer, M.; Bates, M.; et al. "Learning from epidemiological, clinical, and immunological studies on Mycobacterium africanum for improving current understanding of host–pathogen interactions, and for the development and evaluation of diagnostics, host-directed therapies, and vaccines for tuberculosis". International Journal of Infectious Diseases 56 (2017): 126-129. http://www.scopus.com/inward/record.url?eid=2-s2.0-85009443010&partnerID=MN8TOARS.
    10.1016/j.ijid.2016.12.003
  82. Norrby, M.; Vesikari, T.; Lindqvist, L.; Maeurer, M.; Ahmed, R.; Mahdavifar, S.; Bennett, S.; et al. "Safety and immunogenicity of the novel H4:IC31 tuberculosis vaccine candidate in BCG-vaccinated adults: Two phase I dose escalation trials". Vaccine 35 12 (2017): 1652-1661. http://www.scopus.com/inward/record.url?eid=2-s2.0-85013106505&partnerID=MN8TOARS.
    10.1016/j.vaccine.2017.01.055
  83. Lind, A.; Freyhult, E.; Ramelius, A.; Olsson, T.; Arnheim-Dahlström, L.; Lamb, F.; Khademi, M.; et al. "Antibody Affinity Against 2009 A/H1N1 Influenza and Pandemrix Vaccine Nucleoproteins Differs between Childhood Narcolepsy Patients and Controls". Viral Immunology 30 8 (2017): 590-600. http://www.scopus.com/inward/record.url?eid=2-s2.0-85031129535&partnerID=MN8TOARS.
    10.1089/vim.2017.0066
  84. Omazic, B.; Ayoglu, B.; Löhr, M.; Segersvärd, R.; Verbeke, C.; Magalhaes, I.; Potacova, Z.; et al. "A Preliminary Report: Radical Surgery and Stem Cell Transplantation for the Treatment of Patients with Pancreatic Cancer". Journal of Immunotherapy 40 4 (2017): 132-139. http://www.scopus.com/inward/record.url?eid=2-s2.0-85016172220&partnerID=MN8TOARS.
    10.1097/CJI.0000000000000164
  85. Lundberg, J.; Jussing, E.; Liu, Z.; Meng, Q.; Rao, M.; Samén, E.; Grankvist, R.; et al. "Safety of intra-arterial injection with tumor-activated T cells to the rabbit brain evaluated by MRI and SPECT/CT". Cell Transplantation 26 2 (2017): 283-292. http://www.scopus.com/inward/record.url?eid=2-s2.0-85012124618&partnerID=MN8TOARS.
    10.3727/096368916X693347
  86. Petersen, E.; Maeurer, M.; Marais, B.; Migliori, G.B.; Mwaba, P.; Ntoumi, F.; Vilaplana, C.; et al. "World TB Day 2017: Advances, Challenges and Opportunities in the “End-TB” Era". International Journal of Infectious Diseases 56 (2017): 1-5. http://www.scopus.com/inward/record.url?eid=2-s2.0-85013841950&partnerID=MN8TOARS.
    10.1016/j.ijid.2017.02.012
  87. Kroesen, V.M.; Gröschel, M.I.; Martinson, N.; Zumla, A.; Maeurer, M.; van der Werf, T.S.; Vilaplana, C.. "Non-steroidal anti-inflammatory drugs as host-directed therapy for tuberculosis: A systematic review". Frontiers in Immunology 8 JUN (2017): http://www.scopus.com/inward/record.url?eid=2-s2.0-85021697307&partnerID=MN8TOARS.
    10.3389/fimmu.2017.00772
  88. Bomfim, I.L.; Lamb, F.; Fink, K.; Szakács, A.; Silveira, A.; Franzén, L.; Azhary, V.; et al. "The immunogenetics of narcolepsy associated with A(H1N1)pdm09 vaccination (Pandemrix) supports a potent gene-environment interaction". Genes and Immunity 18 2 (2017): 75-81. http://www.scopus.com/inward/record.url?eid=2-s2.0-85015916804&partnerID=MN8TOARS.
    10.1038/gene.2017.1
  89. Nagu, T.J.; Aboud, S.; Matee, M.I.; Maeurer, M.J.; Fawzi, W.W.; Mugusi, F.. "Effects of isoniazid resistance on TB treatment outcomes under programmatic conditions in a high-TB and -HIV setting: a prospective multicentre study". The Journal of antimicrobial chemotherapy 72 3 (2017): 876-881. http://www.scopus.com/inward/record.url?eid=2-s2.0-85031036777&partnerID=MN8TOARS.
    10.1093/jac/dkw503
  90. Girardi, E.; Sañé Schepisi, M.; Goletti, D.; Bates, M.; Mwaba, P.; Yeboah-Manu, D.; Ntoumi, F.; et al. "The global dynamics of diabetes and tuberculosis: the impact of migration and policy implications". International Journal of Infectious Diseases 56 (2017): 45-53. http://www.scopus.com/inward/record.url?eid=2-s2.0-85013435787&partnerID=MN8TOARS.
    10.1016/j.ijid.2017.01.018
  91. Nagu, T.J.; Aboud, S.; Mwiru, R.; Matee, M.I.; Rao, M.; Fawzi, W.W.; Zumla, A.; Maeurer, M.J.; Mugusi, F.. "Tuberculosis associated mortality in a prospective cohort in Sub Saharan Africa: Association with HIV and antiretroviral therapy". International Journal of Infectious Diseases 56 (2017): 39-44. http://www.scopus.com/inward/record.url?eid=2-s2.0-85013498130&partnerID=MN8TOARS.
    10.1016/j.ijid.2017.01.023
  92. Rao, M.; Cadieux, N.; Fitzpatrick, M.; Reed, S.; Arsenian, S.; Valentini, D.; Parida, S.; et al. "Mycobacterium tuberculosis proteins involved in cell wall lipid biosynthesis improve BCG vaccine efficacy in a murine TB model". International Journal of Infectious Diseases 56 (2017): 274-282. http://www.scopus.com/inward/record.url?eid=2-s2.0-85013188421&partnerID=MN8TOARS.
    10.1016/j.ijid.2017.01.024
  93. Malgerud, L.; Lindberg, J.; Wirta, V.; Gustafsson-Liljefors, M.; Karimi, M.; Moro, C.F.; Stecker, K.; et al. "Bioinformatory-assisted analysis of next-generation sequencing data for precision medicine in pancreatic cancer". Molecular Oncology 11 10 (2017): 1413-1429. http://www.scopus.com/inward/record.url?eid=2-s2.0-85028970592&partnerID=MN8TOARS.
    10.1002/1878-0261.12108
  94. Ntoumi, F.; Kaleebu, P.; Macete, E.; Mfinanga, S.; Chakaya, J.; Yeboah-Manu, D.; Bates, M.; et al. "Taking forward the World TB Day 2016 theme 'Unite to End Tuberculosis' for the WHO Africa Region". International Journal of Infectious Diseases 46 (2016): 34-37. http://www.scopus.com/inward/record.url?eid=2-s2.0-84962850898&partnerID=MN8TOARS.
    10.1016/j.ijid.2016.03.003
  95. Maeurer, M.; Rao, M.; Zumla, A.. "Host-directed therapies for antimicrobial resistant respiratory tract infections". Current Opinion in Pulmonary Medicine 22 3 (2016): 203-211. http://www.scopus.com/inward/record.url?eid=2-s2.0-84961231082&partnerID=MN8TOARS.
    10.1097/MCP.0000000000000271
  96. Kabwe, M.; Tembo, J.; Chilukutu, L.; Chilufya, M.; Ngulube, F.; Lukwesa, C.; Kapasa, M.; et al. "Etiology, antibiotic resistance and risk factors for neonatal sepsis in a large referral center in Zambia". Pediatric Infectious Disease Journal 35 7 (2016): e191-e198. http://www.scopus.com/inward/record.url?eid=2-s2.0-84962127825&partnerID=MN8TOARS.
    10.1097/INF.0000000000001154
  97. Zumla, A.; Rao, M.; Dodoo, E.; Maeurer, M.. "Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosis". BMC Medicine 14 1 (2016): http://www.scopus.com/inward/record.url?eid=2-s2.0-84973598834&partnerID=MN8TOARS.
    10.1186/s12916-016-0635-1
  98. Zumla, A.; Rao, M.; Wallis, R.S.; Kaufmann, S.H.E.; Rustomjee, R.; Mwaba, P.; Vilaplana, C.; et al. "Host-directed therapies for infectious diseases: Current status, recent progress, and future prospects". The Lancet Infectious Diseases 16 4 (2016): e47-e63. http://www.scopus.com/inward/record.url?eid=2-s2.0-84962538329&partnerID=MN8TOARS.
    10.1016/S1473-3099(16)00078-5
  99. Meng, Q.; Liu, Z.; Rangelova, E.; Poiret, T.; Ambati, A.; Rane, L.; Xie, S.; et al. "Expansion of tumor-reactive T cells from patients with pancreatic cancer". Journal of Immunotherapy 39 2 (2016): 81-89. http://www.scopus.com/inward/record.url?eid=2-s2.0-84957945015&partnerID=MN8TOARS.
    10.1097/CJI.0000000000000111
  100. Buteme, H.K.; Axelsson-Robertson, R.; Benson, L.; Joloba, M.L.; Boom, W.H.; Kallenius, G.; Maeurer, M.. "Human leukocyte antigen class 1 genotype distribution and analysis in persons with active tuberculosis and household contacts from Central Uganda". BMC Infectious Diseases 16 1 (2016): http://www.scopus.com/inward/record.url?eid=2-s2.0-84992073498&partnerID=MN8TOARS.
    10.1186/s12879-016-1833-3
  101. Wallis, R.S.; Maeurer, M.; Mwaba, P.; Chakaya, J.; Rustomjee, R.; Migliori, G.B.; Marais, B.; et al. "Tuberculosis-advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers". The Lancet Infectious Diseases 16 4 (2016): e34-e46. http://www.scopus.com/inward/record.url?eid=2-s2.0-84962566015&partnerID=MN8TOARS.
    10.1016/S1473-3099(16)00070-0
  102. Bates, M.; Shibemba, A.; Mudenda, V.; Chimoga, C.; Tembo, J.; Kabwe, M.; Chilufya, M.; et al. "Burden of respiratory tract infections at post mortem in Zambian children". BMC Medicine 14 1 (2016): http://www.scopus.com/inward/record.url?eid=2-s2.0-84977138722&partnerID=MN8TOARS.
    10.1186/s12916-016-0645-z
  103. Zumla, A.; Dar, O.; Kock, R.; Muturi, M.; Ntoumi, F.; Kaleebu, P.; Eusebio, M.; et al. "Taking forward a ‘One Health’ approach for turning the tide against the Middle East respiratory syndrome coronavirus and other zoonotic pathogens with epidemic potential". International Journal of Infectious Diseases 47 (2016): 5-9. http://www.scopus.com/inward/record.url?eid=2-s2.0-84979649691&partnerID=MN8TOARS.
    10.1016/j.ijid.2016.06.012
  104. Lamb, F.; Ploner, A.; Fink, K.; Maeurer, M.; Bergman, P.; Piehl, F.; Weibel, D.; Sparén, P.; Dahlström, L.A.. "No Evidence for Disease History as a Risk Factor for Narcolepsy after A(H1N1)pdm09 Vaccination". PloS one 11 4 (2016): http://www.scopus.com/inward/record.url?eid=2-s2.0-85015601920&partnerID=MN8TOARS.
    10.1371/journal.pone.0154296
  105. Zumla, A.; Maeurer, M.. "Host-directed therapies for multidrug resistant tuberculosis". International Journal of Mycobacteriology 5 (2016): S21-S22. http://www.scopus.com/inward/record.url?eid=2-s2.0-85007427360&partnerID=MN8TOARS.
    10.1016/j.ijmyco.2016.09.044
  106. Zumla, A.; Schito, M.; Chakaya, J.; Marais, B.; Mwaba, P.; Migliori, G.B.; Hoelscher, M.; Maeurer, M.; Wallis, R.S.. "World TB Day 2016: Reflections on the global TB emergency". The Lancet Respiratory Medicine 4 4 (2016): 249-251. http://www.scopus.com/inward/record.url?eid=2-s2.0-84963533242&partnerID=MN8TOARS.
    10.1016/S2213-2600(16)00066-7
  107. Li, Q.; Rane, L.; Poiret, T.; Zou, J.; Magalhaes, I.; Ahmed, R.; Du, Z.; et al. "Both high and low levels of cellular Epstein-Barr virus DNA in blood identify failure after hematologic stem cell transplantation in conjunction with acute GVHD and type of conditioning". Oncotarget 7 21 (2016): 30230-30240. http://www.scopus.com/inward/record.url?eid=2-s2.0-84971497779&partnerID=MN8TOARS.
    10.18632/oncotarget.8803
  108. Chiaro, M.D.; Rangelova, E.; Maeurer, M.. "The Ethical Dilemma of Compensating Living Kidney Donors Alignment between Science, Legislation, and Ethical Perception in Society?". JAMA Surgery 151 8 (2016): 716-717. http://www.scopus.com/inward/record.url?eid=2-s2.0-84998775218&partnerID=MN8TOARS.
    10.1001/jamasurg.2016.0092
  109. Qingda Meng; Zhenjiang Liu; Markus Maeurer; Elena Rangelova; Aditya Ambati; Thomas Poiret; Lalit Rane; et al. "Enhanced tumor-infiltrating lymphocytes (eTIL) for cellular therapy of patients with pancreatic cancer or glioblastoma". Journal for ImmunoTherapy of Cancer (2015):
    10.1186/2051-1426-3-S2-P35
  110. Zhenjiang Liu; Qingda Meng; Markus Maeurer; Elena Rangelova; Thomas Poiret; Rebecca Robertson; Aditya Ambati; et al. "IL-2, IL-15 and IL-21 expand T cells for targeted adoptive therapy". Journal for ImmunoTherapy of Cancer (2015):
    10.1186/2051-1426-3-S2-P31
  111. Zumla, A.; Maeurer, M.; Moll, G.; Mayosi, B.M.. "Host-directed therapies for tuberculous pericarditis". International Journal of Infectious Diseases 32 (2015): 30-31. http://www.scopus.com/inward/record.url?eid=2-s2.0-84925271095&partnerID=MN8TOARS.
    10.1016/j.ijid.2014.11.017
  112. Zumla, A.; Maeurer, M.; Marais, B.; Chakaya, J.; Wejse, C.; Lipman, M.; McHugh, T.D.; Petersen, E.. "Commemorating World Tuberculosis Day 2015". International Journal of Infectious Diseases 32 (2015): 1-4. http://www.scopus.com/inward/record.url?eid=2-s2.0-84925261050&partnerID=MN8TOARS.
    10.1016/j.ijid.2015.01.009
  113. Parida, S.K.; Poiret, T.; Zhenjiang, L.; Meng, Q.; Heyckendorf, J.; Lange, C.; Ambati, A.S.; et al. "T-Cell Therapy: Options for Infectious Diseases". Clinical Infectious Diseases 61 (2015): S217-S224. http://www.scopus.com/inward/record.url?eid=2-s2.0-84943409072&partnerID=MN8TOARS.
    10.1093/cid/civ615
  114. Valentini, D.; Ferrara, G.; Advani, R.; Hallander, H.O.; Maeurer, M.J.. "Serum reactome induced by Bordetella pertussis infection and Pertussis vaccines: Qualitative differences in serum antibody recognition patterns revealed by peptide microarray analysis". BMC Immunology 16 1 (2015): http://www.scopus.com/inward/record.url?eid=2-s2.0-84934288097&partnerID=MN8TOARS.
    10.1186/s12865-015-0090-3
  115. Bates, M.; Mudenda, V.; Shibemba, A.; Kaluwaji, J.; Tembo, J.; Kabwe, M.; Chimoga, C.; et al. "Tuberculosis at post-mortem in inpatient adults at a tertiary referral centre in sub-Saharan Africa - A prospective descriptive autopsy study". International Journal of Mycobacteriology (2015): http://www.scopus.com/inward/record.url?eid=2-s2.0-84920903458&partnerID=MN8TOARS.
    10.1016/j.ijmyco.2014.10.054
  116. Zumla, A.; Bates, M.; Maeurer, M.. "Corticosteroid therapy for pneumonia". The Lancet 386 9997 (2015): http://www.scopus.com/inward/record.url?eid=2-s2.0-84941355878&partnerID=MN8TOARS.
    10.1016/S0140-6736(15)00065-3
  117. Zumla, A.; Chakaya, J.; Centis, R.; D'Ambrosio, L.; Mwaba, P.; Bates, M.; Kapata, N.; et al. "Tuberculosis treatment and management-an update on treatment regimens, trials, new drugs, and adjunct therapies". The Lancet Respiratory Medicine 3 3 (2015): 220-234. http://www.scopus.com/inward/record.url?eid=2-s2.0-84924341016&partnerID=MN8TOARS.
    10.1016/S2213-2600(15)00063-6
  118. Zumla, A.; Rustomjee, R.; Ntoumi, F.; Mwaba, P.; Bates, M.; Maeurer, M.; Hui, D.S.; Petersen, E.. "Middle East Respiratory Syndrome - need for increased vigilance and watchful surveillance for MERS-CoV in sub-Saharan African Africa". International Journal of Infectious Diseases 37 (2015): 77-79. http://www.scopus.com/inward/record.url?eid=2-s2.0-84936861568&partnerID=MN8TOARS.
    10.1016/j.ijid.2015.06.020
  119. Rao, M.; Valentini, D.; Poiret, T.; Dodoo, E.; Parida, S.; Zumla, A.; Brighenti, S.; Maeurer, M.. "B in TB: B Cells as Mediators of Clinically Relevant Immune Responses in Tuberculosis". Clinical Infectious Diseases 61 (2015): S225-S234. http://www.scopus.com/inward/record.url?eid=2-s2.0-84943383932&partnerID=MN8TOARS.
    10.1093/cid/civ614
  120. Zumla, A.; Maeurer, M.; Chakaya, J.; Hoelscher, M.; Ntoumi, F.; Rustomjee, R.; Vilaplana, C.; et al. "Towards host-directed therapies for tuberculosis". Nature Reviews Drug Discovery 14 8 (2015): 511-512. http://www.scopus.com/inward/record.url?eid=2-s2.0-84938418174&partnerID=MN8TOARS.
    10.1038/nrd4696
  121. Maeurer, M.; Rao, M.; Zumla, A.. "Host directed therapies (HDTs) and immune response signatures: Insights into a role for interleukin-32". Annals of Translational Medicine 3 (2015): http://www.scopus.com/inward/record.url?eid=2-s2.0-85015466925&partnerID=MN8TOARS.
    10.3978/j.issn.2305-5839.2015.03.65
  122. Ambati, A.; Boas, L.S.V.; Ljungman, P.; Testa, L.; De Oliveira, J.F.; Aoun, M.; Colturato, V.; Maeurer, M.; Machado, C.M.. "Evaluation of pretransplant influenza vaccination in hematopoietic SCT: A randomized prospective study". Bone Marrow Transplantation 50 6 (2015): 858-864. http://www.scopus.com/inward/record.url?eid=2-s2.0-84930375054&partnerID=MN8TOARS.
    10.1038/bmt.2015.47
  123. Parida, S.K.; Axelsson-Robertson, R.; Rao, M.V.; Singh, N.; Master, I.; Lutckii, A.; Keshavjee, S.; et al. "Totally drug-resistant tuberculosis and adjunct therapies". Journal of Internal Medicine 277 4 (2015): 388-405. http://www.scopus.com/inward/record.url?eid=2-s2.0-84925369382&partnerID=MN8TOARS.
    10.1111/joim.12264
  124. Rao, M.; Zumla, A.; Maeurer, M.. "Host-directed therapy: Tuberculosis vaccine development". The Lancet Respiratory Medicine 3 3 (2015): 172-173. http://www.scopus.com/inward/record.url?eid=2-s2.0-84924453299&partnerID=MN8TOARS.
    10.1016/S2213-2600(15)00055-7
  125. Ambati, A.; Einarsdottir, S.; Magalhaes, I.; Poiret, T.; Bodenstein, R.; Leblanc, K.; Brune, M.; Maeurer, M.; Ljungman, P.. "Immunogenicity of virosomal adjuvanted trivalent influenza vaccination in allogeneic stem cell transplant recipients". Transplant Infectious Disease 17 3 (2015): 371-379. http://www.scopus.com/inward/record.url?eid=2-s2.0-84930765005&partnerID=MN8TOARS.
    10.1111/tid.12382
  126. Zumla, A.; Maeurer, M.. "Host-directed therapies for tackling multi-drug resistant tuberculosis: Learning from the pasteur-bechamp debates". Clinical Infectious Diseases 61 9 (2015): 1432-1438. http://www.scopus.com/inward/record.url?eid=2-s2.0-84946753369&partnerID=MN8TOARS.
    10.1093/cid/civ631
  127. Ambati, A.; Valentini, D.; Montomoli, E.; Lapini, G.; Biuso, F.; Wenschuh, H.; Magalhaes, I.; Maeurer, M.. "H1N1 viral proteome peptide microarray predicts individuals at risk for H1N1 infection and segregates infection versus Pandemrix® vaccination". Immunology 145 3 (2015): 357-366. http://www.scopus.com/inward/record.url?eid=2-s2.0-84931578131&partnerID=MN8TOARS.
    10.1111/imm.12448
  128. Feltelius, N.; Persson, I.; Ahlqvist-Rastad, J.; Andersson, M.; Arnheim-Dahlström, L.; Bergman, P.; Granath, F.; et al. "A coordinated cross-disciplinary research initiative to address an increased incidence of narcolepsy following the 2009-2010 Pandemrix vaccination programme in Sweden". Journal of Internal Medicine 278 4 (2015): 335-353. http://www.scopus.com/inward/record.url?eid=2-s2.0-84941025668&partnerID=MN8TOARS.
    10.1111/joim.12391
  129. Zumla, A.; Maeurer, M.. "IFN-¿ release assays for risk assessment in contacts of patients with tuberculosis in low-burden European countries". American Journal of Respiratory and Critical Care Medicine 191 10 (2015): 1101-1103. http://www.scopus.com/inward/record.url?eid=2-s2.0-84938489589&partnerID=MN8TOARS.
    10.1164/rccm.201503-0571ED
  130. Ambati, A.; Poiret, T.; Svahn, B.-M.; Valentini, D.; Khademi, M.; Kockum, I.; Lima, I.; et al. "Increased ß-haemolytic group A streptococcal M6 serotype and streptodornase B-specific cellular immune responses in Swedish narcolepsy cases". Journal of Internal Medicine 278 3 (2015): 264-276. http://www.scopus.com/inward/record.url?eid=2-s2.0-84938739764&partnerID=MN8TOARS.
    10.1111/joim.12355
  131. von Delft, A.; Dramowski, A.; Khosa, C.; Kotze, K.; Lederer, P.; Mosidi, T.; Peters, J.A.; et al. "Why healthcare workers are sick of TB". International Journal of Infectious Diseases 32 (2015): 147-151. http://www.scopus.com/inward/record.url?eid=2-s2.0-84925264201&partnerID=MN8TOARS.
    10.1016/j.ijid.2014.12.003
  132. Zumla, A.; Rao, M.; Parida, S.K.; Keshavjee, S.; Cassell, G.; Wallis, R.; Axelsson-Robertsson, R.; et al. "Inflammation and tuberculosis: Host-directed therapies". Journal of Internal Medicine 277 4 (2015): 373-387. http://www.scopus.com/inward/record.url?eid=2-s2.0-84925365327&partnerID=MN8TOARS.
    10.1111/joim.12256
  133. Bates, M.; Mudenda, V.; Shibemba, A.; Kaluwaji, J.; Tembo, J.; Kabwe, M.; Chimoga, C.; et al. "Burden of tuberculosis at post mortem in inpatients at a tertiary referral centre in sub-Saharan Africa: A prospective descriptive autopsy study". The Lancet Infectious Diseases 15 5 (2015): 544-551. http://www.scopus.com/inward/record.url?eid=2-s2.0-84928208675&partnerID=MN8TOARS.
    10.1016/S1473-3099(15)70058-7
  134. Axelsson-Robertson, R.; Ju, J.H.; Kim, H.-Y.; Zumla, A.; Maeurer, M.. "Mycobacterium tuberculosis-specific and MHC class I-restricted CD8+ T-cells exhibit a stem cell precursor-like phenotype in patients with active pulmonary tuberculosis". International Journal of Infectious Diseases 32 (2015): 13-22. http://www.scopus.com/inward/record.url?eid=2-s2.0-84925246593&partnerID=MN8TOARS.
    10.1016/j.ijid.2014.12.017
  135. Zumla, A.; Azhar, E.I.; Arabi, Y.; Alotaibi, B.; Rao, M.; McCloskey, B.; Petersen, E.; Maeurer, M.. "Host-directed therapies for improving poor treatment outcomes associated with the middle east respiratory syndrome coronavirus infections". International Journal of Infectious Diseases 40 (2015): 71-74. http://www.scopus.com/inward/record.url?eid=2-s2.0-84966263977&partnerID=MN8TOARS.
    10.1016/j.ijid.2015.09.005
  136. Bates, M.; Ahmed, Y.; Kapata, N.; Maeurer, M.; Mwaba, P.; Zumla, A.. "Perspectives on tuberculosis in pregnancy". International Journal of Infectious Diseases 32 (2015): 124-127. http://www.scopus.com/inward/record.url?eid=2-s2.0-84925281262&partnerID=MN8TOARS.
    10.1016/j.ijid.2014.12.014
  137. Parida, S.K.; Madansein, R.; Singh, N.; Padayatchi, N.; Master, I.; Naidu, K.; Zumla, A.; Maeurer, M.. "Cellular therapy in Tuberculosis". International Journal of Infectious Diseases 32 (2015): 32-38. http://www.scopus.com/inward/record.url?eid=2-s2.0-84925262644&partnerID=MN8TOARS.
    10.1016/j.ijid.2015.01.016
  138. Axelsson-Robertson, R.; Rao, M.; Loxton, A.G.; Walzl, G.; Bates, M.; Zumla, A.; Maeurer, M.. "Frequency of Mycobacterium tuberculosis-specific CD8+ T-cells in the course of anti-tuberculosis treatment". International Journal of Infectious Diseases 32 (2015): 23-29. http://www.scopus.com/inward/record.url?eid=2-s2.0-84925249965&partnerID=MN8TOARS.
    10.1016/j.ijid.2015.01.017
  139. Wallstedt, H.; Maeurer, M.. "The History of Tuberculosis Management in Sweden". International Journal of Infectious Diseases 32 (2015): 179-182. http://www.scopus.com/inward/record.url?eid=2-s2.0-84925256627&partnerID=MN8TOARS.
    10.1016/j.ijid.2015.01.018
  140. Madansein, R.; Parida, S.; Padayatchi, N.; Singh, N.; Master, I.; Naidu, K.; Zumla, A.; Maeurer, M.. "Surgical Treatment of Complications of Pulmonary Tuberculosis, including Drug-Resistant Tuberculosis". International Journal of Infectious Diseases 32 (2015): 61-67. http://www.scopus.com/inward/record.url?eid=2-s2.0-84925249927&partnerID=MN8TOARS.
    10.1016/j.ijid.2015.01.019
  141. Schito, M.; Migliori, G.B.; Fletcher, H.A.; McNerney, R.; Centis, R.; D'Ambrosio, L.; Bates, M.; et al. "Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and Vaccines". Clinical Infectious Diseases 61 (2015): S102-S118. http://www.scopus.com/inward/record.url?eid=2-s2.0-84943420049&partnerID=MN8TOARS.
    10.1093/cid/civ609
  142. Schito, M.; Maeurer, M.; Kim, P.; Hanna, D.; Zumla, A.. "Translating the Tuberculosis Research Agenda: Much Accomplished, but Much More to Be Done". Clinical Infectious Diseases 61 (2015): S95-S101. http://www.scopus.com/inward/record.url?eid=2-s2.0-84943428817&partnerID=MN8TOARS.
    10.1093/cid/civ608
  143. Liu zhenjiang; Qingda Meng; Oscar Persson; Bartek Jiri; Thomas Poiret; Lalit Rane; Elena B. Rangelova; Ernest Dodoo; Markus Maeurer. "Rapid expansion of TILs from patients with glioma and recognition of autologous tumor". Journal for ImmunoTherapy of Cancer (2014):
    10.1186/2051-1426-2-S3-P27
  144. Ernest Dodoo; Liu zhenjiang; Bartek Jiri; Oscar Persson; Qingda Meng; Thomas Poiret; Lalit Rane; et al. "Expression of TAAs in glioblastoma and expansion of anti-TAA -reactive T cells". Journal for ImmunoTherapy of Cancer (2014):
    10.1186/2051-1426-2-S3-P24
  145. Qingda Meng; Elena B. Rangelova; Liu zhenjiang; Thomas Poiret; Bartek Jiri; Caroline Verbeke; Ernest Dodoo; Ralf Segersva¨rd; Markus Maeurer. "Generation of tumor-infiltrating lymphocytes from pancreatic cancer lesions for cellular therapy". Journal for ImmunoTherapy of Cancer (2014):
    10.1186/2051-1426-2-S3-P26
  146. Rangelova EB; Meng Q; zhenjiang L; Poiret T; Jiri B; Verbeke C; Dodoo E; Segersvärd R; Maeurer M. "A fast assay to gauge for TAA-reactive T cells in PBMCS from patients with pancreatic cancer.". Journal for immunotherapy of cancer (2014): http://europepmc.org/abstract/PMC/PMC4288614.
    10.1186/2051-1426-2-S3-P25
  147. Meyer-Moock S; Feng YS; Maeurer M; Dippel FW; Kohlmann T. "Systematic literature review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosis.". BMC neurology (2014): http://europepmc.org/abstract/med/24666846.
    10.1186/1471-2377-14-58
  148. Pérez-Bercoff, L.; Valentini, D.; Gaseitsiwe, S.; Mahdavifar, S.; Schutkowski, M.; Poiret, T.; Pérez-Bercoff, A.; Ljungman, P.; Maeurer, M.J.. "Whole CMV proteome pattern recognition analysis after HSCT identifies unique epitope targets associated with the CMV status". PLoS ONE 9 4 (2014): http://www.scopus.com/inward/record.url?eid=2-s2.0-84899687849&partnerID=MN8TOARS.
    10.1371/journal.pone.0089648
  149. Zumla, A.; Memish, Z.A.; Maeurer, M.; Bates, M.; Mwaba, P.; Al-Tawfiq, J.A.; Denning, D.W.; Hayden, F.G.; Hui, D.S.. "Emerging novel and antimicrobial-resistant respiratory tract infections: New drug development and therapeutic options". The Lancet Infectious Diseases 14 11 (2014): 1136-1149. http://www.scopus.com/inward/record.url?eid=2-s2.0-84908278915&partnerID=MN8TOARS.
    10.1016/S1473-3099(14)70828-X
  150. Uhlin, M.; Wikell, H.; Sundin, M.; Blennow, O.; Maeurer, M.; Ringden, O.; Winiarski, J.; et al. "Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation". Haematologica 99 2 (2014): 346-352. http://www.scopus.com/inward/record.url?eid=2-s2.0-84896691028&partnerID=MN8TOARS.
    10.3324/haematol.2013.087338
  151. Kilpeläinen, A.; Axelsson Robertson, R.; Leitner, T.; Sandström, E.; Maeurer, M.; Wahren, B.. "Short communication: HIV-1 nef protein carries multiple epitopes suitable for induction of cellular immunity for an HIV vaccine in Africa". AIDS Research and Human Retroviruses 30 11 (2014): 1065-1071. http://www.scopus.com/inward/record.url?eid=2-s2.0-84931440411&partnerID=MN8TOARS.
    10.1089/aid.2013.0299
  152. Zumla, A.I.; Schito, M.; Maeurer, M.. "Advancing the portfolio of tuberculosis diagnostics, drugs, biomarkers, and vaccines". The Lancet Infectious Diseases 14 4 (2014): 267-269. http://www.scopus.com/inward/record.url?eid=2-s2.0-84896464785&partnerID=MN8TOARS.
    10.1016/S1473-3099(14)70028-3
  153. Maeurer, M.; Zumla, A.. "The host battles drug-Resistant tuberculosis". Science Translational Medicine 6 263 (2014): http://www.scopus.com/inward/record.url?eid=2-s2.0-84911949856&partnerID=MN8TOARS.
    10.1126/scitranslmed.aaa1274
  154. Poiret, T.; Rane, L.; Remberger, M.; Omazic, B.; Gustafsson-Jernberg, T.; Vudattu, N.K.; Ahmed, R.; et al. "Reduced plasma levels of soluble interleukin-7 receptor during graft-versus-host disease (GVHD) in children and adults". BMC Immunology 15 1 (2014): http://www.scopus.com/inward/record.url?eid=2-s2.0-84902742976&partnerID=MN8TOARS.
    10.1186/1471-2172-15-25
  155. Pérez-Bercoff, L.; Vudattu, N.K.; Byrareddy, S.N.; Mattsson, J.; Maeurer, M.; Ljungman, P.. "Reduced IL-7 Responsiveness Defined by Signal Transducer and Activator of Transcription 5 Phosphorylation in T Cells May Be a Marker for Increased Risk of Developing Cytomegalovirus Disease in Patients after Hematopoietic Stem Cell Transplantation". Biology of Blood and Marrow Transplantation 20 1 (2014): 128-132. http://www.scopus.com/inward/record.url?eid=2-s2.0-84890944467&partnerID=MN8TOARS.
    10.1016/j.bbmt.2013.10.006
  156. Zumla, A.; Bates, M.; Maeurer, M.. "Pregnancy and infection.". The New England journal of medicine 371 11 (2014): http://www.scopus.com/inward/record.url?eid=2-s2.0-84907062673&partnerID=MN8TOARS.
  157. Magalhaes, I.; Eriksson, M.; Linde, C.; Muhammad, R.; Rane, L.; Ambati, A.; Axelsson-Robertson, R.; et al. "Difference in immune response in vaccinated and unvaccinated Swedish individuals after the 2009 influenza pandemic". BMC Infectious Diseases 14 1 (2014): http://www.scopus.com/inward/record.url?eid=2-s2.0-84904762027&partnerID=MN8TOARS.
    10.1186/1471-2334-14-319
  158. Lind, A.; Ramelius, A.; Olsson, T.; Arnheim-Dahlström, L.; Lamb, F.; Khademi, M.; Ambati, A.; et al. "A/H1N1 antibodies and TRIB2 autoantibodies in narcolepsy patients diagnosed in conjunction with the Pandemrix vaccination campaign in Sweden 2009-2010". Journal of Autoimmunity 50 (2014): 99-106. http://www.scopus.com/inward/record.url?eid=2-s2.0-84899093017&partnerID=MN8TOARS.
    10.1016/j.jaut.2014.01.031
  159. Zumla, A.; Bates, M.; Maeurer, M.. "To the editor". New England Journal of Medicine 371 11 (2014): http://www.scopus.com/inward/record.url?eid=2-s2.0-84908237800&partnerID=MN8TOARS.
    10.1056/NEJMc1408436
  160. Zumla, A.; Mwaba, P.; Bates, M.; Al-Tawfiq, J.A.; Maeurer, M.; Memish, Z.A.. "The Hajj pilgrimage and surveillance for Middle East Respiratory syndrome coronavirus in pilgrims from African countries.". Tropical medicine & international health : TM & IH 19 7 (2014): 838-840. http://www.scopus.com/inward/record.url?eid=2-s2.0-84905746884&partnerID=MN8TOARS.
    10.1111/tmi.12318
  161. Ahmed, R.K.; Poiret, T.; Ambati, A.; Rane, L.; Remberger, M.; Omazic, B.; Vudattu, N.K.; et al. "TCR+CD4-CD8-T cells in antigen-specific MHC class I-restricted T-cell responses after allogeneic hematopoietic stem cell transplantation". Journal of Immunotherapy 37 8 (2014): 416-425. http://www.scopus.com/inward/record.url?eid=2-s2.0-84925817381&partnerID=MN8TOARS.
    10.1097/CJI.0000000000000047
  162. Maeurer, M.; Schito, M.; Zumla, A.. "Totally-drug-resistant tuberculosis: Hype versus hope". The Lancet Respiratory Medicine 2 4 (2014): 256-257. http://www.scopus.com/inward/record.url?eid=2-s2.0-84897962361&partnerID=MN8TOARS.
    10.1016/S2213-2600(14)70020-7
  163. Maeurer, M.; Magalhaes, I.; Andersson, J.; Ljungman, P.; Sandholm, E.; Uhlin, M.; Mattsson, J.; Ringdén, O.. "Allogeneic hematopoietic cell transplantation for GATA2 deficiency in a patient with disseminated human papillomavirus disease". Transplantation 98 12 (2014): e95-e96. http://www.scopus.com/inward/record.url?eid=2-s2.0-84925843495&partnerID=MN8TOARS.
    10.1097/TP.0000000000000520
  164. Kaufmann, S.H.E.; Lange, C.; Rao, M.; Balaji, K.N.; Lotze, M.; Schito, M.; Zumla, A.I.; Maeurer, M.. "Progress in tuberculosis vaccine development and host-directed therapies-a state of the art review". The Lancet Respiratory Medicine 2 4 (2014): 301-320. http://www.scopus.com/inward/record.url?eid=2-s2.0-84897959389&partnerID=MN8TOARS.
    10.1016/S2213-2600(14)70033-5
  165. Zumla, A.I.; Gillespie, S.H.; Hoelscher, M.; Philips, P.P.J.; Cole, S.T.; Abubakar, I.; McHugh, T.D.; et al. "New antituberculosis drugs, regimens, and adjunct therapies: Needs, advances, and future prospects". The Lancet Infectious Diseases 14 4 (2014): 327-340. http://www.scopus.com/inward/record.url?eid=2-s2.0-84896455574&partnerID=MN8TOARS.
    10.1016/S1473-3099(13)70328-1
  166. Zumla, A.; Al-Tawfiq, J.A.; Enne, V.I.; Kidd, M.; Drosten, C.; Breuer, J.; Muller, M.A.; et al. "Rapid point of care diagnostic tests for viral and bacterial respiratory tract infections-needs, advances, and future prospects". The Lancet Infectious Diseases 14 11 (2014): 1123-1135. http://www.scopus.com/inward/record.url?eid=2-s2.0-84908287355&partnerID=MN8TOARS.
    10.1016/S1473-3099(14)70827-8
  167. Skrahin, A.; Ahmed, R.K.; Ferrara, G.; Rane, L.; Poiret, T.; Isaikina, Y.; Skrahina, A.; Zumla, A.; Maeurer, M.J.. "Autologous mesenchymal stromal cell infusion as adjunct treatment in patients with multidrug and extensively drug-resistant tuberculosis: An open-label phase 1 safety trial". The Lancet Respiratory Medicine 2 2 (2014): 108-122. http://www.scopus.com/inward/record.url?eid=2-s2.0-84895074569&partnerID=MN8TOARS.
    10.1016/S2213-2600(13)70234-0
  168. Marais, B.J.; Lönnroth, K.; Lawn, S.D.; Migliori, G.B.; Mwaba, P.; Glaziou, P.; Bates, M.; et al. "Tuberculosis comorbidity with communicable and non-communicable diseases: Integrating health services and control efforts". The Lancet Infectious Diseases 13 5 (2013): 436-448. http://www.scopus.com/inward/record.url?eid=2-s2.0-84876717473&partnerID=MN8TOARS.
    10.1016/S1473-3099(13)70015-X
  169. Lawn, S.D.; Mwaba, P.; Bates, M.; Piatek, A.; Alexander, H.; Marais, B.J.; Cuevas, L.E.; et al. "Advances in tuberculosis diagnostics: The Xpert MTB/RIF assay and future prospects for a point-of-care test". The Lancet Infectious Diseases 13 4 (2013): 349-361. http://www.scopus.com/inward/record.url?eid=2-s2.0-84875602728&partnerID=MN8TOARS.
    10.1016/S1473-3099(13)70008-2
  170. Bates, M.; O'Grady, J.; Maeurer, M.; Tembo, J.; Chilukutu, L.; Chabala, C.; Kasonde, R.; et al. "Assessment of the Xpert MTB/RIF assay for diagnosis of tuberculosis with gastric lavage aspirates in children in sub-Saharan Africa: A prospective descriptive study". The Lancet Infectious Diseases 13 1 (2013): 36-42. http://www.scopus.com/inward/record.url?eid=2-s2.0-84871084395&partnerID=MN8TOARS.
    10.1016/S1473-3099(12)70245-1
  171. Ashenafi, S.; Aderaye, G.; Zewdie, M.; Raqib, R.; Bekele, A.; Magalhaes, I.; Lema, B.; et al. "BCG-specific IgG-secreting peripheral plasmablasts as a potential biomarker of active tuberculosis in HIV negative and HIV positive patients". Thorax 68 3 (2013): 269-276. http://www.scopus.com/inward/record.url?eid=2-s2.0-84873705010&partnerID=MN8TOARS.
    10.1136/thoraxjnl-2012-201817
  172. Brodin, P.; Valentini, D.; Uhlin, M.; Mattsson, J.; Zumla, A.; Maeurer, M.J.. "Systems level immune response analysis and personalized medicine". Expert Review of Clinical Immunology 9 4 (2013): 307-317. http://www.scopus.com/inward/record.url?eid=2-s2.0-84875951951&partnerID=MN8TOARS.
    10.1586/eci.13.9
  173. Wallis, R.S.; Kim, P.; Cole, S.; Hanna, D.; Andrade, B.B.; Maeurer, M.; Schito, M.; Zumla, A.. "Tuberculosis biomarkers discovery: Developments, needs, and challenges". The Lancet Infectious Diseases 13 4 (2013): 362-372. http://www.scopus.com/inward/record.url?eid=2-s2.0-84875595918&partnerID=MN8TOARS.
    10.1016/S1473-3099(13)70034-3
  174. Marais, B.J.; Graham, S.M.; Maeurer, M.; Zumla, A.. "Progress and challenges in childhood tuberculosis". The Lancet Infectious Diseases 13 4 (2013): 287-289. http://www.scopus.com/inward/record.url?eid=2-s2.0-84875616082&partnerID=MN8TOARS.
    10.1016/S1473-3099(13)70031-8
  175. Zumla, A.; Kim, P.; Maeurer, M.; Schito, M.. "Zero deaths from tuberculosis: Progress, reality, and hope". The Lancet Infectious Diseases 13 4 (2013): 285-287. http://www.scopus.com/inward/record.url?eid=2-s2.0-84875602629&partnerID=MN8TOARS.
    10.1016/S1473-3099(13)70039-2
  176. Alvarez-Corrales, N.; Ahmed, R.K.; Rodriguez, C.A.; Balaji, K.N.; Rivera, R.; Sompallae, R.; Vudattu, N.K.; et al. "Differential cellular recognition pattern to M. tuberculosis targets defined by IFN-¿ and IL-17 production in blood from TB + patients from Honduras as compared to health care workers: TB and immune responses in patients from Honduras". BMC Infectious Diseases 13 1 (2013): http://www.scopus.com/inward/record.url?eid=2-s2.0-84874528365&partnerID=MN8TOARS.
    10.1186/1471-2334-13-125
  177. Axelsson-Robertson, R.; Loxton, A.G.; Walzl, G.; Ehlers, M.M.; Kock, M.M.; Zumla, A.; Maeurer, M.. "A Broad Profile of Co-Dominant Epitopes Shapes the Peripheral Mycobacterium tuberculosis Specific CD8+ T-Cell Immune Response in South African Patients with Active Tuberculosis". PLoS ONE 8 3 (2013): http://www.scopus.com/inward/record.url?eid=2-s2.0-84875420686&partnerID=MN8TOARS.
    10.1371/journal.pone.0058309
  178. Abubakar, I.; Zignol, M.; Falzon, D.; Raviglione, M.; Ditiu, L.; Masham, S.; Adetifa, I.; et al. "Drug-resistant tuberculosis: Time for visionary political leadership". The Lancet Infectious Diseases 13 6 (2013): 529-539. http://www.scopus.com/inward/record.url?eid=2-s2.0-84878434964&partnerID=MN8TOARS.
    10.1016/S1473-3099(13)70030-6
  179. Bates, M.; Ahmed, Y.; Chilukutu, L.; Tembo, J.; Cheelo, B.; Sinyangwe, S.; Kapata, N.; et al. "Use of the Xpert® MTB/RIF assay for diagnosing pulmonary tuberculosis comorbidity and multidrug-resistant TB in obstetrics and gynaecology inpatient wards at the University Teaching Hospital, Lusaka, Zambia". Tropical Medicine and International Health 18 9 (2013): 1134-1140. http://www.scopus.com/inward/record.url?eid=2-s2.0-84881663098&partnerID=MN8TOARS.
    10.1111/tmi.12145
  180. Zumla, A.; Gant, V.; Bates, M.; Mwaba, P.; Maeurer, M.; Memish, Z.A.. "Rapid diagnostics urgently needed for killer infections". The Lancet Respiratory Medicine 1 4 (2013): 284-285. http://www.scopus.com/inward/record.url?eid=2-s2.0-84880046845&partnerID=MN8TOARS.
    10.1016/S2213-2600(13)70099-7
  181. Sayma Rahman; Isabelle Magalhaes; Jubayer Rahman; Raija K. Ahmed; Donata R. Sizemore; Charles A. Scanga; Frank Weichold; et al. "Prime-Boost Vaccination with rBCG/rAd35 Enhances CD8+ Cytolytic T-Cell Responses in Lesions from Mycobacterium Tuberculosis-Infected Primates". Molecular medicine (2012):
    10.2119/molmed.2011.00222
  182. Borgström, E.; Andersen, P.; Atterfelt, F.; Julander, I.; Källenius, G.; Maeurer, M.; Rosenkrands, I.; et al. "Immune Responses to ESAT-6 and CFP-10 by FASCIA and Multiplex Technology for Diagnosis of M. tuberculosis Infection; IP-10 Is a Promising Marker". PLoS ONE 7 11 (2012): http://www.scopus.com/inward/record.url?eid=2-s2.0-84869023628&partnerID=MN8TOARS.
    10.1371/journal.pone.0043438
  183. Uhlin, M.; Mattsson, J.; Maeurer, M.. "Update on viral infections in lung transplantation". Current Opinion in Pulmonary Medicine 18 3 (2012): http://www.scopus.com/inward/record.url?eid=2-s2.0-84859217394&partnerID=MN8TOARS.
    10.1097/MCP.0b013e3283521066
  184. Ferrara, G.; Murray, M.; Winthrop, K.; Centis, R.; Sotgiu, G.; Migliori, G.B.; Maeurer, M.; Zumla, A.. "Risk factors associated with pulmonary tuberculosis: Smoking, diabetes and anti-TNFa drugs". Current Opinion in Pulmonary Medicine 18 3 (2012): http://www.scopus.com/inward/record.url?eid=2-s2.0-84859215760&partnerID=MN8TOARS.
    10.1097/MCP.0b013e328351f9d6
  185. Uhlin, M.; Andersson, J.; Zumla, A.; Maeurer, M.. "Adjunct immunotherapies for tuberculosis". Journal of Infectious Diseases 205 SUPPL. 2 (2012): http://www.scopus.com/inward/record.url?eid=2-s2.0-84860380066&partnerID=MN8TOARS.
    10.1093/infdis/jis197
  186. Axelsson-Robertson, R.; Magalhaes, I.; Parida, S.K.; Zumla, A.; Maeurer, M.. "The immunological footprint of mycobacterium tuberculosis t-cell epitope recognition". Journal of Infectious Diseases 205 SUPPL. 2 (2012): http://www.scopus.com/inward/record.url?eid=2-s2.0-84860361345&partnerID=MN8TOARS.
    10.1093/infdis/jis198
  187. Uhlin, M.; Gertow, J.; Uzunel, M.; Okas, M.; Berglund, S.; Watz, E.; Brune, M.; et al. "Rapid salvage treatment with virus-specific T cells for therapy-resistant disease". Clinical Infectious Diseases 55 8 (2012): 1064-1073. http://www.scopus.com/inward/record.url?eid=2-s2.0-84866645392&partnerID=MN8TOARS.
    10.1093/cid/cis625
  188. Pasetto, A.; Frelin, L.; Brass, A.; Yasmeen, A.; Koh, S.; Lohmann, V.; Bartenschlager, R.; et al. "Generation of T-cell receptors targeting a genetically stable and immunodominant cytotoxic T-lymphocyte epitope within hepatitis C virus non-structural protein 3". Journal of General Virology 93 2 (2012): http://www.scopus.com/inward/record.url?eid=2-s2.0-84855954396&partnerID=MN8TOARS.
    10.1099/vir.0.037903-0
  189. Zumla, A.; Maeurer, M.. "Rational development of adjunct immune-based therapies for drug-resistant tuberculosis: Hypotheses and experimental designs". Journal of Infectious Diseases 205 SUPPL. 2 (2012): http://www.scopus.com/inward/record.url?eid=2-s2.0-84860382392&partnerID=MN8TOARS.
    10.1093/infdis/jir881
  190. Zumla, A.; Atun, R.; Maeurer, M.; Kim, P.S.; Jean-Philippe, P.; Hafner, R.; Schito, M.. "Eliminating tuberculosis and tuberculosis-HIV co-disease in the 21st century: Key perspectives, controversies, unresolved issues, and needs". Journal of Infectious Diseases 205 SUPPL. 2 (2012): http://www.scopus.com/inward/record.url?eid=2-s2.0-84860362270&partnerID=MN8TOARS.
    10.1093/infdis/jir880
  191. Bates, M.; O'Grady, J.; Mwaba, P.; Chilukutu, L.; Mzyece, J.; Cheelo, B.; Chilufya, M.; et al. "Evaluation of the burden of unsuspected pulmonary tuberculosis and co-morbidity with non-communicable diseases in sputum producing adult inpatients". PLoS ONE 7 7 (2012): http://www.scopus.com/inward/record.url?eid=2-s2.0-84864409083&partnerID=MN8TOARS.
    10.1371/journal.pone.0040774
  192. Mudenda, V.; Lucas, S.; Shibemba, A.; O'Grady, J.; Bates, M.; Kapata, N.; Schwank, S.; et al. "Tuberculosis and tuberculosis/HIV/AIDS-associated mortality in Africa: The urgent need to expand and invest in routine and research autopsies". Journal of Infectious Diseases 205 SUPPL. 2 (2012): http://www.scopus.com/inward/record.url?eid=2-s2.0-84860367355&partnerID=MN8TOARS.
    10.1093/infdis/jir859
  193. Zumla, A.; Abubakar, I.; Raviglione, M.; Hoelscher, M.; Ditiu, L.; McHugh, T.D.; Squire, S.B.; et al. "Drug-Resistant tuberculosis-current dilemmas, unanswered questions, challenges, and priority needs". Journal of Infectious Diseases 205 SUPPL. 2 (2012): http://www.scopus.com/inward/record.url?eid=2-s2.0-84860368544&partnerID=MN8TOARS.
    10.1093/infdis/jir858
  194. McNerney, R.; Maeurer, M.; Abubakar, I.; Marais, B.; McHugh, T.D.; Ford, N.; Weyer, K.; et al. "Tuberculosis diagnostics and biomarkers: Needs, challenges, recent advances, and opportunities". Journal of Infectious Diseases 205 SUPPL. 2 (2012): http://www.scopus.com/inward/record.url?eid=2-s2.0-84860356467&partnerID=MN8TOARS.
    10.1093/infdis/jir860
  195. O'Grady, J.; Bates, M.; Chilukutu, L.; Mzyece, J.; Cheelo, B.; Chilufya, M.; Mukonda, L.; et al. "Evaluation of the xpert MTB/RIF assay at a tertiary care referral hospital in a setting where tuberculosis and hiv infection are highly endemic". Clinical Infectious Diseases 55 9 (2012): 1171-1178. http://www.scopus.com/inward/record.url?eid=2-s2.0-84867550821&partnerID=MN8TOARS.
    10.1093/cid/cis631
  196. Karbach, J.; Neumann, A.; Brand, K.; Wahle, C.; Siegel, E.; Maeurer, M.; Ritter, E.; et al. "Phase I clinical trial of mixed bacterial vaccine (Coley's toxins) in patients with NY-ESO-1 expressing cancers: Immunological effects and clinical activity". Clinical Cancer Research 18 19 (2012): 5449-5459. http://www.scopus.com/inward/record.url?eid=2-s2.0-84866931873&partnerID=MN8TOARS.
    10.1158/1078-0432.CCR-12-1116
  197. Ahmed, R.K.; Rohava, Z.; Balaji, K.N.; Hoffner, S.E.; Gaines, H.; Magalhaes, I.; Zumla, A.; Skrahina, A.; Maeurer, M.J.. "Pattern recognition and cellular immune responses to novel Mycobacterium tuberculosis-antigens in individuals from Belarus". BMC Infectious Diseases 12 (2012): http://www.scopus.com/inward/record.url?eid=2-s2.0-84857004803&partnerID=MN8TOARS.
    10.1186/1471-2334-12-41
  198. Ferrara, G.; Zumla, A.; Maeurer, M.. "Intravenous immunoglobulin (IVIg) for refractory and difficult-to-treat infections". American Journal of Medicine 125 10 (2012): http://www.scopus.com/inward/record.url?eid=2-s2.0-84866504065&partnerID=MN8TOARS.
    10.1016/j.amjmed.2012.01.023
  199. McNerney, R.; Ferrara, G.; O'Grady, J.; Maeurer, M.; Zumla, A.. "Screening of immigrants in the UK for latent tuberculosis". Expert Review of Respiratory Medicine 5 4 (2011): 483-486. http://www.scopus.com/inward/record.url?eid=2-s2.0-80052623343&partnerID=MN8TOARS.
    10.1586/ers.11.45
  200. Mwaba, P.; Mcnerney, R.; Grobusch, M.P.; O'Grady, J.; Bates, M.; Kapata, N.; Maeurer, M.; Zumla, A.. "Achieving STOP TB Partnership goals: Perspectives on development of new diagnostics, drugs and vaccines for tuberculosis". Tropical Medicine and International Health 16 7 (2011): 819-827. http://www.scopus.com/inward/record.url?eid=2-s2.0-79958782008&partnerID=MN8TOARS.
    10.1111/j.1365-3156.2011.02777.x
  201. O'Grady, J.; Maeurer, M.; Atun, R.; Abubakare, I.; Mwaba, P.; Bates, M.; Kapata, N.; et al. "Tuberculosis in prisons: Anatomy of global neglect". European Respiratory Journal 38 4 (2011): 752-754. http://www.scopus.com/inward/record.url?eid=2-s2.0-80053533337&partnerID=MN8TOARS.
    10.1183/09031936.00041211
  202. Ferrara, G.; O'Grady, J.; Zumla, A.; Maeurer, M.. "Xpert MTB/RIF test for tuberculosis". The Lancet 378 9790 (2011): http://www.scopus.com/inward/record.url?eid=2-s2.0-79961227419&partnerID=MN8TOARS.
    10.1016/S0140-6736(11)61244-0
  203. Axelsson-Robertson, R.; Ahmed, R.K.; Weichold, F.F.; Ehlers, M.M.; Kock, M.M.; Sizemore, D.; Sadoff, J.; Maeurer, M.. "Human leukocyte antigens A*3001 and A*3002 show distinct peptide-binding patterns of the Mycobacterium tuberculosis protein TB10.4: Consequences for immune recognition". Clinical and Vaccine Immunology 18 1 (2011): 125-134. http://www.scopus.com/inward/record.url?eid=2-s2.0-78650913859&partnerID=MN8TOARS.
    10.1128/CVI.00302-10
  204. O'Grady, J.; Maeurer, M.; Mwaba, P.; Kapata, N.; Bates, M.; Hoelscher, M.; Zumla, A.. "New and improved diagnostics for detection of drug-resistant pulmonary tuberculosis". Current Opinion in Pulmonary Medicine 17 3 (2011): 134-141. http://www.scopus.com/inward/record.url?eid=2-s2.0-79953870493&partnerID=MN8TOARS.
    10.1097/MCP.0b013e3283452346
  205. O'Grady, J.; Hoelscher, M.; Atun, R.; Bates, M.; Mwaba, P.; Kapata, N.; Ferrara, G.; Maeurer, M.; Zumla, A.. "Tuberculosis in prisons in sub-Saharan Africa - The need for improved health services, surveillance and control". Tuberculosis 91 2 (2011): 173-178. http://www.scopus.com/inward/record.url?eid=2-s2.0-79952490339&partnerID=MN8TOARS.
    10.1016/j.tube.2010.12.002
  206. Andres, S.; Schmidt, H.-M.A.; Mitchell, H.; Rhen, M.; Maeurer, M.; Engstrand, L.. "Helicobacter pyloridefines local immune response through interaction with dendritic cells". FEMS Immunology and Medical Microbiology 61 2 (2011): 168-178. http://www.scopus.com/inward/record.url?eid=2-s2.0-79951472105&partnerID=MN8TOARS.
    10.1111/j.1574-695X.2010.00761.x
  207. Rane, L.; Rahman, S.; Magalhaes, I.; Ahmed, R.; Spångberg, M.; Kondova, I.; Verreck, F.; et al. "Increased (6 exon) interleukin-7 production after M. tuberculosis infection and soluble interleukin-7 receptor expression in lung tissue". Genes and Immunity 12 7 (2011): 513-522. http://www.scopus.com/inward/record.url?eid=2-s2.0-80054859838&partnerID=MN8TOARS.
    10.1038/gene.2011.29
  208. Almqvist, C.; Adami, H.-O.; Franks, P.W.; Groop, L.; Ingelsson, E.; Kere, J.; Lissner, L.; et al. "LifeGene - A large prospective population-based study of global relevance". European Journal of Epidemiology 26 1 (2011): 67-77. http://www.scopus.com/inward/record.url?eid=2-s2.0-79151483327&partnerID=MN8TOARS.
    10.1007/s10654-010-9521-x
  209. Ludvigsson, J.F.; Sanders, D.S.; Maeurer, M.; Jonsson, J.; Grunewald, J.; Wahlström, J.. "Potential confounders in observed association between coeliac disease and tuberculosis: Authors' reply". Alimentary Pharmacology and Therapeutics 33 10 (2011): 1176-1177. http://www.scopus.com/inward/record.url?eid=2-s2.0-79954588602&partnerID=MN8TOARS.
    10.1111/j.1365-2036.2011.04645.x
  210. Ferrara, G.; Parida, S.K.; Zumla, A.; Richeldi, L.; Maeurer, M.; Ferrara G; Parida SK; et al. "A decade of interferon-¿ release assays: Quest for the holy grail to diagnose latent infection with Mycobacterium tuberculosis?". American Journal of Respiratory and Critical Care Medicine 183 12 (2011): http://www.scopus.com/inward/record.url?eid=2-s2.0-80051559943&partnerID=MN8TOARS.
    10.1164/ajrccm.183.12.1732
  211. Omar, H.; Ahmed, R.; Rane, L.; Björklund, A.; Gustafsson-Jernberg, A.; Ljungman, P.; Maeurer, M.J.. "Decreased IL-7 signaling in T cells from patients with PTLD after allogeneic HSCT". Journal of Immunotherapy 34 4 (2011): 390-396. http://www.scopus.com/inward/record.url?eid=2-s2.0-79955591917&partnerID=MN8TOARS.
    10.1097/CJI.0b013e318215e31b
  212. Ludvigsson, J.F.; Sanders, D.S.; Maeurer, M.; Jonsson, J.; Grunewald, J.; Wahlström, J.. "Risk of tuberculosis in a large sample of patients with coeliac disease - A nationwide cohort study". Alimentary Pharmacology and Therapeutics 33 6 (2011): 689-696. http://www.scopus.com/inward/record.url?eid=2-s2.0-79951682960&partnerID=MN8TOARS.
    10.1111/j.1365-2036.2010.04572.x
  213. Zumla, A.; Atun, R.; Maeurer, M.; Mwaba, P.; Ma, Z.; O'Grady, J.; Bates, M.; et al. "Viewpoint: Scientific dogmas, paradoxes and mysteries of latent Mycobacterium tuberculosis infection". Tropical Medicine and International Health 16 1 (2011): 79-83. http://www.scopus.com/inward/record.url?eid=2-s2.0-78650211749&partnerID=MN8TOARS.
    10.1111/j.1365-3156.2010.02665.x
  214. Borgström, E.; Andersen, P.; Andersson, L.; Julander, I.; Källenius, G.; Maeurer, M.; Norrby, M.; et al. "Detection of proliferative responses to ESAT-6 and CFP-10 by FASCIA assay for diagnosis of Mycobacterium tuberculosis infection". Journal of Immunological Methods 370 1-2 (2011): 55-64. http://www.scopus.com/inward/record.url?eid=2-s2.0-79960038090&partnerID=MN8TOARS.
    10.1016/j.jim.2011.05.008
  215. Rane, L.; Vudattu, N.; Bourcier, K.; Graniar, E.; Hillert, J.; Seyfert, V.; Maeurer, M. J.. "Alternative splicing of interleukin-7 (IL-7) and interleukin-7 receptor alpha (IL-7Ra) in peripheral blood from patients with multiple sclerosis (MS)". Journal of Neuroimmunology 222 1-2 (2010): 82-86. http://www.scopus.com/inward/record.url?eid=2-s2.0-77952289509&partnerID=MN8TOARS.
    10.1016/j.jneuroim.2010.02.014
  216. Gaseitsiwe, S.; Valentini, D.; Mahdavifar, S.; Reilly, M.; Ehrnst, A.; Maeurer, M.. "Peptide microarray-based identification of Mycobacterium tuberculosis epitope binding to HLA-DRB1*0101, DRB1*1501, and DRB1*0401". Clinical and Vaccine Immunology 17 1 (2010): 168-175. http://www.scopus.com/inward/record.url?eid=2-s2.0-74549183647&partnerID=MN8TOARS.
    10.1128/CVI.00208-09
  217. Valentini, D.; Gaseitsiwe, S.; Maeurer, M.. "Humoral 'reactome' profiles using peptide microarray chips". Trends in Immunology 31 11 (2010): 399-400. http://www.scopus.com/inward/record.url?eid=2-s2.0-78049282755&partnerID=MN8TOARS.
    10.1016/j.it.2010.08.007
  218. Moors, M.; Vudattu, N.K.; Abel, J.; Krämer, U.; Rane, L.; Ulfig, N.; Ceccatelli, S.; et al. "Interleukin-7 (IL-7) and IL-7 splice variants affect differentiation of human neural progenitor cells". Genes and Immunity 11 1 (2010): 11-20. http://www.scopus.com/inward/record.url?eid=2-s2.0-75049085393&partnerID=MN8TOARS.
    10.1038/gene.2009.77
  219. Maeurer, M.. "Markus Maeurer on the LifeGene project". Expert Review of Clinical Immunology 6 5 (2010): 709-712. http://www.scopus.com/inward/record.url?eid=2-s2.0-77956534329&partnerID=MN8TOARS.
    10.1586/eci.10.62
  220. Axelsson-Robertson, R.; Weichold, F.; Sizemore, D.; Wulf, M.; Skeiky, Y.A.W.; Sadoff, J.; Maeurer, M.J.. "Extensive major histocompatibility complex class I binding promiscuity for Mycobacterium tuberculosis TB10.4 peptides and immune dominance of human leucocyte antigen (HLA)-B*0702 and HLA-B*0801 alleles in TB10.4 CD8+T-cell responses". Immunology 129 4 (2010): 496-505. http://www.scopus.com/inward/record.url?eid=2-s2.0-77949409919&partnerID=MN8TOARS.
    10.1111/j.1365-2567.2009.03201.x
  221. Magalhaes, I.; Vudattu, N.K.; Ahmed, R.K.; Kühlmann-Berenzon, S.; Ngo, Y.; Sizemore, D.R.; Wehlin, L.; et al. "High content cellular immune profiling reveals differences between rhesus monkeys and men". Immunology 131 1 (2010): 128-140. http://www.scopus.com/inward/record.url?eid=2-s2.0-77955141810&partnerID=MN8TOARS.
    10.1111/j.1365-2567.2010.03284.x
  222. Britten CM; Janetzki S; Ben-Porat L; Clay TM; Kalos M; Maecker H; Odunsi K; et al. "Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium.". Cancer immunology, immunotherapy : CII (2009): http://europepmc.org/abstract/med/19259668.
    10.1007/s00262-009-0681-z
  223. Gaseitsiwe, S.; Valentini, D.; Ahmed, R.; Mahdavifar, S.; Magalhaes, I.; Zerweck, J.; Schutkowski, M.; et al. "Major histocompatibility complex class II molecule-human immunodeficiency virus peptide analysis using a microarray chip". Clinical and Vaccine Immunology 16 4 (2009): 567-573. http://www.scopus.com/inward/record.url?eid=2-s2.0-64549095249&partnerID=MN8TOARS.
    10.1128/CVI.00441-08
  224. Ngo, Y.; Advani, R.; Valentini, D.; Gaseitsiwe, S.; Mahdavifar, S.; Maeurer, M.; Reilly, M.. "Identification and testing of control peptides for antigen microarrays". Journal of Immunological Methods 343 2 (2009): 68-78. http://www.scopus.com/inward/record.url?eid=2-s2.0-63749099541&partnerID=MN8TOARS.
    10.1016/j.jim.2008.12.004
  225. Vudattu, N.K.; Magalhaes, I.; Hoehn, H.; Pan, D.; Maeurer, M.J.. "Expression analysis and functional activity of interleukin-7 splice variants". Genes and Immunity 10 2 (2009): 132-140. http://www.scopus.com/inward/record.url?eid=2-s2.0-61849143338&partnerID=MN8TOARS.
    10.1038/gene.2008.90
  226. Vudattu, N.K.; Kuhlmann-Berenzon, S.; Khademi, M.; Seyfert, V.; Olsson, T.; Maeurer, M.J.. "Increased numbers of IL-7 receptor molecules on CD4+CD25-CD107a+ T-cells in patients with autoimmune diseases affecting the central nervous system". PLoS ONE 4 8 (2009): http://www.scopus.com/inward/record.url?eid=2-s2.0-68349139357&partnerID=MN8TOARS.
    10.1371/journal.pone.0006534
  227. Al-Nawas, B.; Walter, C.; Morbach, T.; Seitner, N.; Siegel, E.; Maeurer, M.; Krummenauer, F.. "Clinical and microbiological efficacy of moxifloxacin versus amoxicillin/clavulanic acid in severe odontogenic abscesses: A pilot study". European Journal of Clinical Microbiology and Infectious Diseases 28 1 (2009): 75-82. http://www.scopus.com/inward/record.url?eid=2-s2.0-58149149942&partnerID=MN8TOARS.
    10.1007/s10096-008-0587-2
  228. Veldsman, C.; Kock, M.M.; Rossouw, T.; Nieuwoudt, M.; Maeurer, M.; Hoosen, A.A.; Ehlers, M.M.. "QuantiFERON-TB GOLD ELISA assay for the detection of Mycobacterium tuberculosis-specific antigens in blood specimens of HIV-positive patients in a high-burden country". FEMS Immunology and Medical Microbiology 57 3 (2009): 269-273. http://www.scopus.com/inward/record.url?eid=2-s2.0-71049153246&partnerID=MN8TOARS.
    10.1111/j.1574-695X.2009.00610.x
  229. Magalhaes, I.; Vudattu, N.K.; Jäger, E.; Maeurer, M.J.. "Tumor antigen-specific t-cells are present in the cd8aa+ T-cell Effector-memory Pool". Journal of Immunotherapy 31 9 (2008): 840-848. http://www.scopus.com/inward/record.url?eid=2-s2.0-56849114008&partnerID=MN8TOARS.
    10.1097/CJI.0b013e31818883a1
  230. Gaseitsiwe, S.; Valentini, D.; Mahdavifar, S.; Magalhaes, I.; Hoft, D.F.; Zerweck, J.; Schutkowski, M.; et al. "Pattern recognition in pulmonary tuberculosis defined by high content peptide microarray chip analysis representing 61 proteins from M. tuberculosis". PLoS ONE 3 12 (2008): http://www.scopus.com/inward/record.url?eid=2-s2.0-57549100397&partnerID=MN8TOARS.
    10.1371/journal.pone.0003840
  231. Al-Nawas, B.; Maeurer, M.. "Severe versus local odontogenic bacterial infections: Comparison of microbial isolates". European Surgical Research 40 2 (2008): 220-224. http://www.scopus.com/inward/record.url?eid=2-s2.0-39149106091&partnerID=MN8TOARS.
    10.1159/000110864
  232. Magalhaes, I.; Sizemore, D.R.; Ahmed, R.K.; Mueller, S.; Wehlin, L.; Scanga, C.; Weichold, F.; et al. "rBCG induces strong antigen-specific T cell responses in Rhesus Macaques in a prime-boost setting with an adenovirus 35 tuberculosis vaccine vector". PLoS ONE 3 11 (2008): http://www.scopus.com/inward/record.url?eid=2-s2.0-56849108004&partnerID=MN8TOARS.
    10.1371/journal.pone.0003790
  233. Vudattu, N.K.; Magalhaes, I.; Schmidt, M.; Seyfert-Margolis, V.; Maeurer, M.J.. "Reduced numbers of IL-7 receptor (CD127) expressing immune cells and IL-7-signaling defects in peripheral blood from patients with breast cancer". International Journal of Cancer 121 7 (2007): 1512-1519. http://www.scopus.com/inward/record.url?eid=2-s2.0-34548291989&partnerID=MN8TOARS.
    10.1002/ijc.22854
  234. Zehbe, I.; Kaufmann, A.M.; Schmidt, M.; Hohn, H.; Maeurer, M.J.. "Human papillomavirus 16 E6-specific CD45RA+ CCR7+ high avidity CD8+ T cells fail to control tumor growth despite interferon-¿ production in patients with cervical cancer". Journal of Immunotherapy 30 5 (2007): 523-532. http://www.scopus.com/inward/record.url?eid=2-s2.0-34250838681&partnerID=MN8TOARS.
    10.1097/CJI.0b013e31803240fa
  235. Weichold, F.F.; Mueller, S.; Kortsik, C.; Hitzler, W.E.; Wulf, M.J.; Hone, D.M.; Sadoff, J.C.; Maeurer, M.J.. "Impact of MHC class I alleles on the M. tuberculosis antigen-specific CD8+T-cell response in patients with pulmonary tuberculosis". Genes and Immunity 8 4 (2007): 334-343. http://www.scopus.com/inward/record.url?eid=2-s2.0-34250015227&partnerID=MN8TOARS.
    10.1038/sj.gene.6364392
  236. Karbach, J.; Gnjatic, S.; Pauligk, C.; Bender, A.; Maeurer, M.; Schultze, J.L.; Nadler, K.; et al. "Tumor-reactive CD8+ T-cell clones in patients after NY-ESO-1 peptide vaccination". International Journal of Cancer 121 9 (2007): 2042-2048. http://www.scopus.com/inward/record.url?eid=2-s2.0-34648836563&partnerID=MN8TOARS.
    10.1002/ijc.22957
  237. Maeurer, M.. "High-content T-cell and B-cell analysis". Clinical Reviews in Allergy and Immunology 32 1 (2007): 75-83. http://www.scopus.com/inward/record.url?eid=2-s2.0-34247174864&partnerID=MN8TOARS.
    10.1007/s12016-007-0022-y
  238. Nahtman, T.; Jernberg, A.; Mahdavifar, S.; Zerweck, J.; Schutkowski, M.; Maeurer, M.; Reilly, M.. "Validation of peptide epitope microarray experiments and extraction of quality data". Journal of Immunological Methods 328 1-2 (2007): 1-13. http://www.scopus.com/inward/record.url?eid=2-s2.0-35548964148&partnerID=MN8TOARS.
    10.1016/j.jim.2007.07.015
  239. Höhn, H.; Kortsik, C.; Zehbe, I.; Hitzler, W.E.; Kayser, K.; Freitag, K.; Neukirch, C.; et al. "MHC class II tetramer guided detection of Mycobacterium tuberculosis-specific CD4+ T cells in peripheral blood from patients with pulmonary tuberculosis". Scandinavian Journal of Immunology 65 5 (2007): 467-478. http://www.scopus.com/inward/record.url?eid=2-s2.0-34247539128&partnerID=MN8TOARS.
    10.1111/j.1365-3083.2007.01924.x
  240. Durinovic-Belló, I.; Rosinger, S.; Olson, J.A.; Congia, M.; Ahmad, R.C.; Rickert, M.; Hampl, J.; et al. "DRB1*0401-restricted human T cell clone specific for the major proinsulin73-90 epitope expresses a down-regulatory T helper 2 phenotype". Proceedings of the National Academy of Sciences of the United States of America 103 31 (2006): 11683-11688. http://www.scopus.com/inward/record.url?eid=2-s2.0-33746835005&partnerID=MN8TOARS.
    10.1073/pnas.0603682103
  241. Zehbe, I.; Schmidt, M.; Maeurer, M.; Leo, C.; Höckel, M.; Pilch, H.. "Different T-cell receptor (TCR) zeta chain expression in cervical cancer and its precursor lesions". Zentralblatt fur Gynakologie 128 5 (2006): 266-270. http://www.scopus.com/inward/record.url?eid=2-s2.0-33749606658&partnerID=MN8TOARS.
    10.1055/s-2006-933423
  242. Oerke, S.; Höhn, H.; Zehbe, I.; Pilch, H.; Schicketanz, K.-H.; Hitzler, W.E.; Neukirch, C.; Freitag, K.; Maeurer, M.J.. "Naturally processed and HLA-B8-presented HPV16 E7 epitope recognized by T cells from patients with cervical cancer". International Journal of Cancer 114 5 (2005): 766-778. http://www.scopus.com/inward/record.url?eid=2-s2.0-14844291701&partnerID=MN8TOARS.
    10.1002/ijc.20794
  243. Kiesslich, R.; Goetz, M.; Burg, J.; Stolte, M.; Siegel, E.; Maeurer, M.J.; Thomas, S.; et al. "Diagnosing Helicobacter pylori in vivo by confocal laser endoscopy". Gastroenterology 128 7 (2005): 2119-2123. http://www.scopus.com/inward/record.url?eid=2-s2.0-20444468395&partnerID=MN8TOARS.
    10.1053/j.gastro.2004.12.035
  244. Tully, G.; Kortsik, C.; Höhn, H.; Zehbe, I.; Hitzler, W.E.; Neukirch, C.; Freitag, K.; Kayser, K.; Maeurer, M.J.. "Highly focused T cell responses in latent human pulmonary Mycobacterium tuberculosis infection". Journal of Immunology 174 4 (2005): 2174-2184. http://www.scopus.com/inward/record.url?eid=2-s2.0-13544271153&partnerID=MN8TOARS.
    10.4049/jimmunol.174.4.2174
  245. Zehbe, I.; Höhn, H.; Pilch, H.; Neukirch, C.; Freitag, K.; Maeurer, M.J.. "Differential MHC class II component expression in HPV-positive cervical cancer cells: Implication for immune surveillance". International Journal of Cancer 117 5 (2005): 807-815. http://www.scopus.com/inward/record.url?eid=2-s2.0-27744569920&partnerID=MN8TOARS.
    10.1002/ijc.21226
  246. Pilch, H.; Schmidt, M.; Steiner, E.; Seufert, R.; Jensen, A.; Nilges, K.; Maeurer, M.. "New tetramer technology offers new aspects in the definition of appropriate HPV target epitopes for novel vaccine designs in cervical cancer patients". Geburtshilfe und Frauenheilkunde 65 3 (2005): 297-302. http://www.scopus.com/inward/record.url?eid=2-s2.0-16444381924&partnerID=MN8TOARS.
    10.1055/s-2005-837534
  247. Degauque, N.; Schadendorf, D.; Brouard, S.; Guillet, M.; Sébille, F.; Höhn, H.; Pallier, A.; et al. "Blood T-cell Vß transcriptome in melanoma patients". International Journal of Cancer 110 5 (2004): 721-729. http://www.scopus.com/inward/record.url?eid=2-s2.0-2942547445&partnerID=MN8TOARS.
    10.1002/ijc.20149
  248. Maeurer, Markus. "[Ceftriaxone versus Levofloxacin for antibiotic therapy in patients with acute cholangitis]". Zeitschrift fur Gastroenterologie (2003): https://doi.org/10.1055/s-2003-36676.
    10.1055/s-2003-36676
  249. Höhn, H.; Jülch, M.; Pilch, H.; Kortsik, C.; Tully, G.; Neukirch, C.; Freitag, K.; Maeurer, M.. "Definition of the HLA-A2 restricted peptides recognized by human CD8+effector T cells by flow-assisted sorting of the CD8+CD45RA+CD28-T cell subpopulation". Clinical and Experimental Immunology 131 1 (2003): 102-110. http://www.scopus.com/inward/record.url?eid=2-s2.0-12244293433&partnerID=MN8TOARS.
    10.1046/j.1365-2249.2003.02036.x
  250. Höhn, H.; Kortsik, C.; Tully, G.; Nilges, K.; Necker, A.; Freitag, K.; Neukirch, C.; et al. "Longitudinal analysis of Mycobacterium tuberculosis 19-kDa antigen-specific T cells in patients with pulmonary tuberculosis: Association with disease activity and cross-reactivity to a peptide from HIVenvgp120". European Journal of Immunology 33 6 (2003): 1613-1623. http://www.scopus.com/inward/record.url?eid=2-s2.0-0038758943&partnerID=MN8TOARS.
    10.1002/eji.200323480
  251. Xu, S.; Koski, G.K.; Faries, M.; Bedrosian, I.; Mick, R.; Maeurer, M.; Cheever, M.A.; Cohen, P.A.; Czerniecki, B.J.. "Rapid high efficiency sensitization of CD8+T cells to tumor antigens by dendritic cells leads to enhanced functional avidity and direct tumor recognition through an IL-12-dependent mechanism". Journal of Immunology 171 5 (2003): 2251-2261. http://www.scopus.com/inward/record.url?eid=2-s2.0-0042931259&partnerID=MN8TOARS.
    10.4049/jimmunol.171.5.2251
  252. Nilges, K.; Höhn, H.; Pilch, H.; Neukirch, C.; Freitag, K.; Talbot, P.J.; Maeurer, M.J.. "Human papillomavirus type 16 E7 peptide-directed CD8+T cells from patients with cervical cancer are cross-reactive with the coronavirus NS2 protein". Journal of Virology 77 9 (2003): 5464-5474. http://www.scopus.com/inward/record.url?eid=2-s2.0-0344080581&partnerID=MN8TOARS.
    10.1128/JVI.77.9.5464-5474.2003
  253. Carrabba, M.G.; Castelli, C.; Maeurer, M.J.; Squarcina, P.; Cova, A.; Pilla, L.; Renkvist, N.; Parmiani, G.; Rivoltini, L.. "Suboptimal activation of CD8+T cells by melanoma-derived altered peptide ligands: Role of melan-A/MART-1 optimized analogues". Cancer Research 63 7 (2003): 1560-1567. http://www.scopus.com/inward/record.url?eid=2-s2.0-0037379961&partnerID=MN8TOARS.
  254. Maeurer, M.J.; Necker, A.; Salter, R.D.; Castelli, C.; Höhn, H.; Karbach, J.; Freitag, K.; et al. "Cancer risk in persons receiving prescriptions for paracetamol: A Danish cohort study". International Journal of Cancer 97 1 (2002): 96-101. http://www.scopus.com/inward/record.url?eid=2-s2.0-0036131816&partnerID=MN8TOARS.
    10.1002/ijc.1581
  255. Pilch, H.; Höhn, H.; Neukirch, C.; Freitag, K.; Knapstein, P.G.; Tanner, B.; Maeurer, M.J.. "Antigen-driven T-cell selection in patients with cervical cancer as evidenced by T-cell receptor analysis and recognition of autologous tumor". Clinical and Diagnostic Laboratory Immunology 9 2 (2002): 267-278. http://www.scopus.com/inward/record.url?eid=2-s2.0-0036129892&partnerID=MN8TOARS.
    10.1128/CDLI.9.2.267-278.2002
  256. Jäger, E.; Salter, R.; Castelli, C.; Höhn, H.; Freitag, K.; Karbach, J.; Neukirch, C.; et al. "Impact of antigen presentation on TCR modulation and cytokine release: Implications for detection and sorting of antigen-specific CD8+T cells using HLA-A2 wild-type or HLA-A2 mutant tetrameric complexes". Journal of Immunology 168 6 (2002): 2766-2772. http://www.scopus.com/inward/record.url?eid=2-s2.0-0037087477&partnerID=MN8TOARS.
    10.4049/jimmunol.168.6.2766
  257. Maeurer, M.J.; Necker, A.; Salter, R.D.; Castelli, C.; Höhn, H.; Karbach, J.; Freitag, K.; et al. "Improved detection of melanoma antigen-specific T cells expressing low or high levels of CD8 by HLA-A2 tetramers presenting a Melan-A/MART-1 peptide analogue". International Journal of Cancer 97 1 (2002): 64-71. http://www.scopus.com/inward/record.url?eid=2-s2.0-0036132044&partnerID=MN8TOARS.
    10.1002/ijc.1580
  258. Zschausch, H.-C.E.; Han, S.-R.; Meyer, H.-G.W.; Maeurer, M.J.. "No association between Helicobacter pylori genotypes and antibiotic resistance phenotypes within families". Helicobacter 7 6 (2002): 364-366. http://www.scopus.com/inward/record.url?eid=2-s2.0-0036934264&partnerID=MN8TOARS.
    10.1046/j.1523-5378.2002.00111.x
  259. Pilch, H.; Höhn, H.; Freitag, K.; Neukirch, C.; Necker, A.; Haddad, P.; Tanner, B.; Knapstein, P.G.; Maeurer, M.J.. "Improved assessment of T-cell receptor (TCR) VB repertoire in clinical specimens: Combination of TCR-CDR3 spectratyping with flow cytometry-based TCR VB frequency analysis". Clinical and Diagnostic Laboratory Immunology 9 2 (2002): 257-266. http://www.scopus.com/inward/record.url?eid=2-s2.0-0036127889&partnerID=MN8TOARS.
    10.1128/CDLI.9.2.257-266.2002
  260. Fiedler, T.; Walter, W.; Reichert, T.E.; Maeurer, M.J.. "Regulation of CD1d expression by murine tumor cells: Escape from immunosurveillance or alternate target molecules?". International Journal of Cancer 98 3 (2002): 389-397. http://www.scopus.com/inward/record.url?eid=2-s2.0-0037139401&partnerID=MN8TOARS.
    10.1002/ijc.10141
  261. Tully, G.; Jäger, E.; Maeurer, M.J.. "Detection of antigen-specific T-cells with MHC/peptide-tetramer-complexes". Clinical and Applied Immunology Reviews 2 6 (2002): 345-356. http://www.scopus.com/inward/record.url?eid=2-s2.0-12144288557&partnerID=MN8TOARS.
    10.1016/S1529-1049(02)00056-9
  262. Höhn, H.; Neukirch, C.; Freitag, K.; Necker, A.; Hitzler, W.; Seliger, B.; Maeurer, M.J.. "Longitudinal analysis of the T-cell receptor (TCR)-VA and -VB repertoire in CD8+T cells from individuals immunized with recombinant hepatitis B surface antigen". Clinical and Experimental Immunology 129 2 (2002): 309-317. http://www.scopus.com/inward/record.url?eid=2-s2.0-0036381754&partnerID=MN8TOARS.
    10.1046/j.1365-2249.2002.01841.x
  263. Jäger, E.; Höhn, H.; Necker, A.; Förster, R.; Karbach, J.; Freitag, K.; Neukirch, C.; et al. "Peptide-specific CD8+ T-cell evolution in vivo: Response to peptide vaccination with Melan-A/MART-1". International Journal of Cancer 98 3 (2002): 376-388. http://www.scopus.com/inward/record.url?eid=2-s2.0-0037139370&partnerID=MN8TOARS.
    10.1002/ijc.10165
  264. Hoffmann, T.K.; Loftus, D.J.; Nakano, K.; Maeurer, M.J.; Chikamatsu, K.; Appella, E.; Whiteside, T.L.; DeLeo, A.B.. "The ability of variant peptides to reverse the nonresponsiveness of T lymphocytes to the wild-type sequence p53264-272epitope". Journal of Immunology 168 3 (2002): 1338-1347. http://www.scopus.com/inward/record.url?eid=2-s2.0-0036467454&partnerID=MN8TOARS.
    10.4049/jimmunol.168.3.1338
  265. Pilch, H.; Hoehn, H.; Schmidt, M.; Steiner, E.; Tanner, B.; Seufert, R.; Maeurer, M.. "CD8+CD45RA+CD27-CD28-T-cell subset in PBL of cervical cancer patients representing CD8+T-cells being able to recognize cervical cancer associated antigens provided by HPV 16 E7". Zentralblatt fur Gynakologie 124 8-9 (2002): 406-412. http://www.scopus.com/inward/record.url?eid=2-s2.0-0344837686&partnerID=MN8TOARS.
    10.1055/s-2002-38130
  266. Jäger, E.; Karbach, J.; Gnjatic, S.; Jäger, D.; Maeurer, M.; Atmaca, A.; Arand, M.; et al. "Identification of a naturally processed NY-ESO-1 peptide recognized by CD8+ T cells in the context of HLA-B51.". Cancer immunity : a journal of the Academy of Cancer Immunology 2 (2002): http://www.scopus.com/inward/record.url?eid=2-s2.0-0038049133&partnerID=MN8TOARS.
  267. Ritz U; Momburg F; Pilch H; Huber C; Maeurer MJ; Seliger B; Ritz, U.; et al. "Deficient expression of components of the MHC class I antigen processing machinery in human cervical carcinoma.". International journal of oncology 19 6 (2001): 1211-1220. http://europepmc.org/abstract/med/11713591.
    10.3892/ijo.19.6.1211
  268. Lüder CG; Walter W; Beuerle B; Maeurer MJ; Gross U; Lüder, C.G.K.; Walter, W.; et al. "Toxoplasma gondii down-regulates MHC class II gene expression and antigen presentation by murine macrophages via interference with nuclear translocation of STAT1alpha.". European journal of immunology 31 5 (2001): 1475-1484. http://europepmc.org/abstract/med/11465104.
    10.1002/1521-4141(200105)31:5<1475::aid-immu1475>3.0.co;2-c
  269. Höhn, H.; Kortsik, C.; Nilges, K.; Necker, A.; Freitag, K.; Tully, G.; Neukirch, C.; Maeurer, M.J.. "Human leucocyte antigena-2 restricted and Mycobacterium tuberculosis 19-kDa antigen-specific CD8+T-cell responses are oligoclonal and exhibit a T-cell cytotoxic type 2 response cytokine-secretion pattern". Immunology 104 3 (2001): 278-288. http://www.scopus.com/inward/record.url?eid=2-s2.0-0034746802&partnerID=MN8TOARS.
    10.1046/j.1365-2567.2001.01307.x
  270. Walter, W.; Scheuer, C.; Loos, M.; Reichert, T.E.; Maeurer, M.J.. "H2-Mß1 and H2-Mß2 Heterodimers Equally Promote CLIP Removal in I-AqMolecules from Autoimmune-prone DBA/1 Mice". Journal of Biological Chemistry 276 14 (2001): 11086-11091. http://www.scopus.com/inward/record.url?eid=2-s2.0-0035815748&partnerID=MN8TOARS.
    10.1074/jbc.M006521200
  271. Pilch, H.; Günzel, S.; Schäffer, U.; Tanner, B.; Brockerhoff, P.; Maeurer, M.; Höckel, M.; Hommel, G.; Knapstein, P.G.. "Human papillomavirus (HPV) DNA in primary cervical cancer and in cancer free pelvic lymph nodes - Correlation with clinico-pathological parameters and prognostic significance". Zentralblatt fur Gynakologie 123 2 (2001): 91-101. http://www.scopus.com/inward/record.url?eid=2-s2.0-0035123367&partnerID=MN8TOARS.
    10.1055/s-2001-12411
  272. Seitzer, U.; Kayser, K.; Höhn, H.; Entzian, P.; Wacker, H.-H.; Ploetz, S.; Flad, H.-D.; Gerdes, J.; Maeurer, M.J.. "Reduced T-cell receptor CD3¿-chain protein and sustained CD3e expression at the site of mycobacterial infection". Immunology 104 3 (2001): 269-277. http://www.scopus.com/inward/record.url?eid=2-s2.0-0035169534&partnerID=MN8TOARS.
    10.1046/j.1365-2567.2001.01323.x
  273. Maeurer, M.; Höhn, H.; Castelli, C.; Salter, R.; Necker, A.; Reichert, T.; Knuth, A.; Jäger, E.; Viola, A.. "Antigen recognition by T cells: A strong sense of structure [2] (multiple letters)". Trends in Immunology 22 11 (2001): 599-601. http://www.scopus.com/inward/record.url?eid=2-s2.0-0035499138&partnerID=MN8TOARS.
    10.1016/S1471-4906(01)02061-0
  274. Sun, Y.; Song, M.; Maeurer, M.J.; Schadendorf, D.. "Segregation of effector mechanisms in a tumour-specific CD8 T-cell clone correlates with CD30 expression". Scandinavian Journal of Immunology 54 3 (2001): 314-320. http://www.scopus.com/inward/record.url?eid=2-s2.0-0035720441&partnerID=MN8TOARS.
    10.1046/j.1365-3083.2001.00971.x
  275. Kießlich, R.; Holfelder, M.; Will, D.; Hahn, M.; Nafe, B.; Genitsariotis, R.; Daniello, S.; Maeurer, M.; Jung, M.. "Interventional ERCP in patients with cholestasis. Degree of biliary bacterial colonization and antibiotic resistance | Interventionelle ERCP bei patienten mit cholestase: Häufigkeit und antibiotikaresistenz der biliären keimbesiedlung". Zeitschrift fur Gastroenterologie 39 12 (2001): 985-992. http://www.scopus.com/inward/record.url?eid=2-s2.0-0035689141&partnerID=MN8TOARS.
    10.1055/s-2001-19026
  276. Pilch, H.; Günzel, S.; Schäffer, U.; Tanner, B.; Brockerhoff, P.; Maeurer, M.; Höckel, M.; Hommel, G.; Knapstein, P.G.. "The presence of HPV DNA in cervical cancer: Correlation with clinico-pathologic parameters and prognostic significance: 10 years experience at-the Department of Obstetrics and Gynecology of the Mainz University". International Journal of Gynecological Cancer 11 1 (2001): 39-48. http://www.scopus.com/inward/record.url?eid=2-s2.0-0035107042&partnerID=MN8TOARS.
    10.1046/j.1525-1438.2001.011001039.x
  277. Schindel C; Siepmann U; Han S; Ullmann AJ; Mayer E; Fischer T; Maeurer M; et al. "Persistent Legionella infection in a patient after bone marrow transplantation.". Journal of clinical microbiology 38 11 (2000): 4294-4295. http://europepmc.org/abstract/med/11060117.
  278. Jäger, E.; Maeurer, M.; Höhn, H.; Karbach, J.; Jäger, D.; Zidianakis, Z.; Bakhshandeh-Bath, A.; et al. "Clonal expansion of Melan A-specific cytotoxic T lymphocytes in a melanoma patient responding to continued immunization with melanoma- associated peptides". International Journal of Cancer 86 4 (2000): 538-547. http://www.scopus.com/inward/record.url?eid=2-s2.0-0343729873&partnerID=MN8TOARS.
    10.1002/(SICI)1097-0215(20000515)86:4<538::AID-IJC16>3.0.CO;2-G
  279. Han, S.-R.; Schindel, C.; Genitsariotis, R.; Märker-Hermann, E.; Bhakdi, S.; Maeurer, M.J.; Han S; et al. "Identification of a unique Helicobacter species by 16S rRNA gene analysis in an abdominal abscess from a patient with X-linked hypogammaglobulinemia". Journal of Clinical Microbiology 38 7 (2000): 2740-2742. http://www.scopus.com/inward/record.url?eid=2-s2.0-0033931106&partnerID=MN8TOARS.
  280. Han, S.-R.; Zschausch, H.-C.E.; Meyer, H.-G.W.; Schneider, T.; Loos, M.; Bhakdi, S.; Maeurer, M.J.; et al. "Helicobacter pylori: Clonal population structure and restricted transmission within families revealed by molecular typing". Journal of Clinical Microbiology 38 10 (2000): 3646-3651. http://www.scopus.com/inward/record.url?eid=2-s2.0-0033775265&partnerID=MN8TOARS.
  281. Ullmann, A.J.; Helmreich-Becker, I.; Maeurer, M.J.; Han, S.-R.; Heussel, C.P.; Koehler, H.H.; Fischer, T.; Huber, C.. "Hepatic granuloma due to Propionibacterium aches in a patient with acute myelogenous leukemia". Clinical Infectious Diseases 30 1 (2000): 219-220. http://www.scopus.com/inward/record.url?eid=2-s2.0-0033968883&partnerID=MN8TOARS.
    10.1086/313625
  282. Höhn, H.; Pilch, H.; Günzel, S.; Neukirch, C.; Freitag, K.; Necker, A.; Maeurer, M.J.. "Human papillomavirus type 33 E7 peptides presented by HLA-DR*0402 to tumor-infiltrating T cells in cervical cancer". Journal of Virology 74 14 (2000): 6632-6636. http://www.scopus.com/inward/record.url?eid=2-s2.0-0343081027&partnerID=MN8TOARS.
    10.1128/JVI.74.14.6632-6636.2000
  283. Walter, W.; Lingnau, K.; Schmitt, E.; Loos, M.; Maeurer, M.J.; Walter W; Lingnau K; et al. "MHC class II antigen presentation pathway in murine tumours: Tumour evasion from immunosurveillance?". British Journal of Cancer 83 9 (2000): 1192-1201. http://www.scopus.com/inward/record.url?eid=2-s2.0-0033753861&partnerID=MN8TOARS.
    10.1054/bjoc.2000.1415
  284. Maeurer, M.J.. "Interleukin-7 in health and disease". Electronic Journal of Pathology and Histology 6 2 (2000): 63-82. http://www.scopus.com/inward/record.url?eid=2-s2.0-0034578565&partnerID=MN8TOARS.
  285. Helmreich-Becker, I.; Maeurer, M.; Galle, P.R.; Lohse, A.W.. "Granulomatous hepatitis in an immunocompromised patient diagnosed by minilaparoscopy.". Endoscopy 32 5 (2000): http://www.scopus.com/inward/record.url?eid=2-s2.0-19244368867&partnerID=MN8TOARS.
  286. Seliger, B.; Maeurer, M.J.; Ferrone, S.. "Antigen-processing machinery breakdown and tumor growth". Immunology Today 21 9 (2000): 455-464. http://www.scopus.com/inward/record.url?eid=2-s2.0-0033827817&partnerID=MN8TOARS.
    10.1016/S0167-5699(00)01692-3
  287. Pilch, H.; Gunzel, S.; Freitag, C.; Schaffer, U.; Tanner, B.; Knapstein, P.G.; Maeurer, M.. "Expansion of the CD8+CD45RA + CD27 - CD28 - T-cell subset in patients with HPV-associated cervical cancer and its precursors". Geburtshilfe und Frauenheilkunde 60 9 (2000): 464-468. http://www.scopus.com/inward/record.url?eid=2-s2.0-0033826810&partnerID=MN8TOARS.
    10.1055/s-2000-8019
  288. Trinder, P.K.E.; Hickling, T.P.; Sim, R.B.; Brackertz, D.; Loos, M.; Maeurer, M.J.. "Humoral autoreactivity directed against surfactant protein-A (SP-A) in rheumatoid arthritis synovial fluids". Clinical and Experimental Immunology 120 1 (2000): 183-187. http://www.scopus.com/inward/record.url?eid=2-s2.0-0034110114&partnerID=MN8TOARS.
    10.1046/j.1365-2249.2000.01185.x
  289. Maeurer, M.J.; Trinder, P.; Hommel, G.; Walter, W.; Freitag, K.; Atkins, D.; Störkel, S.. "Interleukin-7 or interleukin-15 enhances survival of Mycobacterium tuberculosis-infected mice". Infection and Immunity 68 5 (2000): 2962-2970. http://www.scopus.com/inward/record.url?eid=2-s2.0-0034114110&partnerID=MN8TOARS.
    10.1128/IAI.68.5.2962-2970.2000
  290. Pilch, H.; Höhn, H.; Günzel, S.; Schäffen, U.; Seelig, R.; Seeliger, B.; Maeurer, M.J.; Knapstein, P.G.. "Cervical cancer cells present HPV-E7 epitope to CD4+ tumor infiltrating lymphocytes (TIL) in association with histocompatibility leukocyte antigen (HLA) DR4: Identification of HPV-peptides by CD4+ t-cells". Geburtshilfe und Frauenheilkunde 60 1 (2000): 35-40. http://www.scopus.com/inward/record.url?eid=2-s2.0-17544394912&partnerID=MN8TOARS.
    10.1055/s-2000-9771
  291. Walter, W.; Scheuer, C.; Lingnau, K.; Reichert, T.E.; Schmitt, E.; Loos, M.; Maeurer, M.J.. "H2-M, be faciliator of MHC class II peptide loading, and its negative modulator H2-O are differentially expressed in response to proinflammatory cytokines". Immunogenetics 51 10 (2000): 794-804. http://www.scopus.com/inward/record.url?eid=2-s2.0-0033862355&partnerID=MN8TOARS.
    10.1007/s002510000210
  292. Han SR; Schneider T; Loos M; Bhakdi S; Maeurer MJ. "One-step polymerase chain reaction-based typing of Helicobacter pylori vacA gene: association with gastric histopathology.". Medical microbiology and immunology (1999): http://europepmc.org/abstract/med/10776843.
    10.1007/s004300050115
  293. Höhn H; Pilch H; Günzel S; Neukirch C; Hilmes C; Kaufmann A; Seliger B; Maeurer MJ. "CD4+ tumor-infiltrating lymphocytes in cervical cancer recognize HLA-DR-restricted peptides provided by human papillomavirus-E7.". Journal of immunology (Baltimore, Md. : 1950) (1999): http://europepmc.org/abstract/med/10553103.
  294. Höhn H; Reichert T; Neukirch C; Pilch H; Maeurer MJ. "Monoclonal TCR mRNA transcripts are preferentially detected in the TCR variable alpha chain in CD8(+) T-lymphocytes: implications for immunomonitoring.". International journal of molecular medicine (1999): http://europepmc.org/abstract/med/9917520.
    10.3892/ijmm.3.2.139
  295. Trinder P; Seitzer U; Gerdes J; Seliger B; Maeurer M. "Constitutive and IFN-gamma regulated expression of IL-7 and IL-15 in human renal cell cancer.". International journal of oncology (1999): http://europepmc.org/abstract/med/9863005.
    10.3892/ijo.14.1.23
  296. Han, S.-R.; Bhakdi, S.; Maeurer, M.J.; Schneider, T.; Gehring, S.; Han SR; Bhakdi S; et al. "Stable and unstable amoxicillin resistance in Helicobacter pylori: Should antibiotic resistance testing be performed prior to eradication therapy?". Journal of Clinical Microbiology 37 8 (1999): 2740-2741. http://www.scopus.com/inward/record.url?eid=2-s2.0-0032788224&partnerID=MN8TOARS.
  297. Walter, W.; Loos, M.; Maeurer, M.J.. "Differential expression of alternative H2-M isoforms in B cells, dendritic cells and macrophages by proinflammatory cytokines". Molecular Immunology 36 11-12 (1999): 733-743. http://www.scopus.com/inward/record.url?eid=2-s2.0-0033178127&partnerID=MN8TOARS.
    10.1016/S0161-5890(99)00089-9
  298. Jäger, E.; Höhn, H.; Karbach, J.; Momburg, F.; Castelli, C.; Knuth, A.; Seliger, B.; et al. "Cytotoxic T lymphocytes define multiple peptide isoforms derived from the melanoma-associated antigen MART-1/Melan-A". International Journal of Cancer 81 6 (1999): 979-984. http://www.scopus.com/inward/record.url?eid=2-s2.0-0032968598&partnerID=MN8TOARS.
    10.1002/(SICI)1097-0215(19990611)81:6<979::AID-IJC22>3.0.CO;2-Y
  299. Maeurer, M.J.; Seliger, B.; Trinder, P.; Gerdes, J.; Seitzer, U.. "Interleukin-15 in mycobacterial infection of antigen-presenting cells". Scandinavian Journal of Immunology 50 3 (1999): 280-288. http://www.scopus.com/inward/record.url?eid=2-s2.0-0032774679&partnerID=MN8TOARS.
    10.1046/j.1365-3083.1999.00593.x
  300. Trinder, P.K.E.; Märker-Hermann, E.; Loos, M.; Maeurer, M.J.. "Functional definition of a B cell epitope, KGEQGEPGA, on C1q the Fc- binding subunit of the first component of complement". Scandinavian Journal of Immunology 50 6 (1999): 635-641. http://www.scopus.com/inward/record.url?eid=2-s2.0-0032704684&partnerID=MN8TOARS.
    10.1046/j.1365-3083.1999.00649.x
  301. Maeurer MJ; Lotze MT; Maeurer, M.J.; Lotze, M.T.. "Interleukin-7 (IL-7) knockout mice. Implications for lymphopoiesis and organ-specific immunity.". International reviews of immunology 16 3-4 (1998): 309-322. http://europepmc.org/abstract/med/9505193.
    10.3109/08830189809042999
  302. Tjandrawan, T.; Martin, D.M.; Maeurer, M.J.; Castelli, C.; Lotze, M.T.; Storkus, W.J.. "Third keystone symposium on cellular immunology and the immunotherapy of cancer antigen processing and presentation autologous human dendriphages pulsed with synthetic or natural tumor peptides elicit tumor-specific CTLs in vitro". Journal of Immunotherapy 21 2 (1998): 157-149. http://www.scopus.com/inward/record.url?eid=2-s2.0-85026149165&partnerID=MN8TOARS.
  303. Han, S.-R.; Schreiber, H.-J.; Bhakdi, S.; Loos, M.; Maeurer, M.J.; Han SR; Schreiber HJ; et al. "vacA genotypes and genetic diversity in clinical isolates of Helicobacter pylori". Clinical and Diagnostic Laboratory Immunology 5 2 (1998): 139-145. http://www.scopus.com/inward/record.url?eid=2-s2.0-0031949482&partnerID=MN8TOARS.
  304. Tjandrawan, T.; Martin, D.M.; Maeurer, M.J.; Castelli, C.; Lotze, M.T.; Storkus, W.J.. "Autologous human dendriphages pulsed with synthetic or natural tumor peptides elicit tumor-specific CTLs in vitro". Journal of Immunotherapy 21 2 (1998): 149-157. http://www.scopus.com/inward/record.url?eid=2-s2.0-0031936881&partnerID=MN8TOARS.
    10.1097/00002371-199803000-00009
  305. Maeurer MJ; Walter W; Martin D; Zitvogel L; Elder E; Storkus W; Lotze MT; et al. "Interleukin-7 (IL-7) in colorectal cancer: IL-7 is produced by tissues from colorectal cancer and promotes preferential expansion of tumour infiltrating lymphocytes.". Scandinavian journal of immunology 45 2 (1997): 182-192. http://europepmc.org/abstract/med/9042431.
    10.1046/j.1365-3083.1997.d01-384.x
  306. Maeurer, M.; Seitzer, U.; Trinder, P.; Walter, W.; Gerdes, J.; Loos, M.; Seliger, B.; Bhakdi, S.. "The physiology of IL-15 regulation: IL-15 in infections with intracellular bacterias". Immunobiology 197 2-4 (1997): 328-329. http://www.scopus.com/inward/record.url?eid=2-s2.0-0030797875&partnerID=MN8TOARS.
  307. Trinder, P.K.E.; Maeurer, M.J.; Stoerkel, S.S.; Loos, M.. "Altered (oxidized) C1q induces a rheumatoid arthritis-like destructive and chronic inflammation in joint structures in arthritis-susceptible rats". Clinical Immunology and Immunopathology 82 2 (1997): 149-156. http://www.scopus.com/inward/record.url?eid=2-s2.0-0031081250&partnerID=MN8TOARS.
    10.1006/clin.1996.4293
  308. Maeurer, M.J.; Lotze, M.T.. "Tumor Recognition by the Cellular Immune System: New Aspects of Tumor Immunology". International Reviews of Immunology 14 42038 (1997): 97-132. http://www.scopus.com/inward/record.url?eid=2-s2.0-0030944457&partnerID=MN8TOARS.
    10.3109/08830189709116848
  309. Walter, W.; Jin, S.; Loos, M.; Maeurer, M.J.. "Differential regulation of H2-M molecules by TH1 (IFN-¿) or TH2 (IL-4, IL-10) associated cytokines". Immunobiology 197 2-4 (1997): 154-155. http://www.scopus.com/inward/record.url?eid=2-s2.0-0030885895&partnerID=MN8TOARS.
  310. Seliger, B.; Maeurer, M.J.; Ferrone, S.. "Tap off - tumors on". Immunology Today 18 6 (1997): 292-299. http://www.scopus.com/inward/record.url?eid=2-s2.0-0031172370&partnerID=MN8TOARS.
    10.1016/s0167-5699(97)80026-6
  311. Bernhard H; Maeurer MJ; Jäger E; Wölfel T; Schneider J; Karbach J; Seliger B; et al. "Recognition of human renal cell carcinoma and melanoma by HLA-A2-restricted cytotoxic T lymphocytes is mediated by shared peptide epitopes and up-regulated by interferon-gamma.". Scandinavian journal of immunology 44 3 (1996): 285-292. http://europepmc.org/abstract/med/8795723.
    10.1046/j.1365-3083.1996.d01-304.x
  312. Maeurer MJ; Gollin SM; Storkus WJ; Swaney W; Karbach J; Martin D; Castelli C; et al. "Tumor escape from immune recognition: loss of HLA-A2 melanoma cell surface expression is associated with a complex rearrangement of the short arm of chromosome 6.". Clinical cancer research : an official journal of the American Association for Cancer Research 2 4 (1996): 641-652. http://europepmc.org/abstract/med/9816214.
  313. Maeurer MJ; Martin D; Elder E; Storkus WJ; Lotze MT. "Detection of naturally processed and HLA-A1-presented melanoma T-cell epitopes defined by CD8(+) T-cells' release of granulocyte-macrophage colony-stimulating factor but not by cytolysis.". Clinical cancer research : an official journal of the American Association for Cancer Research (1996): http://europepmc.org/abstract/med/9816095.
  314. Maeurer, M.J.; Martin, D.; Walter, W.; Liu, K.; Zitvogel, L.; Halusczcak, K.; Rabinowich, H.; et al. "Human intestinal Vd1+T lymphocytes recognize tumor cells of epithelial origin". Journal of Experimental Medicine 183 4 (1996): 1681-1696. http://www.scopus.com/inward/record.url?eid=2-s2.0-0029665819&partnerID=MN8TOARS.
    10.1084/jem.183.4.1681
  315. Trinder, P.K.E.; Maeurer, M.J.; Brackertz, D.; Loos, M.; Trinder PK; Maeurer MJ; Brackertz D; Loos M. "The collagen-like component of the complement system, C1q, is recognized by 7 S autoantibodies and is functionally impaired in synovial fluids of patients with rheumatoid arthritis". Immunology 87 3 (1996): 355-361. http://www.scopus.com/inward/record.url?eid=2-s2.0-0029936747&partnerID=MN8TOARS.
    10.1046/j.1365-2567.1996.495559.x
  316. Zitvogel, L.; Robbins, P.D.; Storkus, W.J.; Clarke, M.R.; Maeurer, M.J.; Campbell, R.L.; Davis, C.G.; et al. "Interleukin-12 and B7.1 co-stimulation cooperate in the induction of effective antitumor immunity and therapy of established tumors". European Journal of Immunology 26 6 (1996): 1335-1341. http://www.scopus.com/inward/record.url?eid=2-s2.0-9044245302&partnerID=MN8TOARS.
    10.1002/eji.1830260624
  317. Maeurer, M.J.; Storkus, W.J.; Kirkwood, J.M.; Lotze, M.T.. "New treatment options for patients with melanoma: Review of melanoma-derived T-cell epitope-based peptide vaccines". Melanoma Research 6 1 (1996): 11-24. http://www.scopus.com/inward/record.url?eid=2-s2.0-0030043549&partnerID=MN8TOARS.
    10.1097/00008390-199602000-00003
  318. Bernhard, H.; Jäger, E.; Maeurer, M.J.; Meyer Zum Büschenfelde, K.H.; Knuth, A.. "Tumor associated antigens in human renal cell carcinoma: MHC restricted recognition by cytotoxic T lymphocytes". Tissue Antigens 48 1 (1996): 22-31. http://www.scopus.com/inward/record.url?eid=2-s2.0-0029820314&partnerID=MN8TOARS.
    10.1111/j.1399-0039.1996.tb02601.x
  319. Maeurer, M.J.; Gollin, S.M.; Martin, D.; Swaney, W.; Bryant, J.; Castelli, C.; Robbins, P.; et al. "Tumor escape from immune recognition: Lethal recurrent melanoma in a patient associated with downregulation of the peptide transporter protein TAP-1 and loss of expression of the immunodominant MART-1/Melan-A antigen". Journal of Clinical Investigation 98 7 (1996): 1633-1641. http://www.scopus.com/inward/record.url?eid=2-s2.0-10144223555&partnerID=MN8TOARS.
    10.1172/JCI118958
  320. Maeurer, M.J.; Chan, H.-W.; Karbach, J.; Salter, R.D.; Knuth, A.; Lotze, M.T.; Storkus, W.J.. "Amino acid substitutions at position 97 in HLA-A2 segregate cytolysis from cytokine release in MART-1/Melan-A peptide AAGIGILTV-specific cytotoxic T lymphocytes". European Journal of Immunology 26 11 (1996): 2613-2623. http://www.scopus.com/inward/record.url?eid=2-s2.0-0029908917&partnerID=MN8TOARS.
    10.1002/eji.1830261112
  321. Walter, W.; Loos, M.; Maeurer, M.J.. "H2-M polymorphism in mice susceptible to collagen-induced arthritis involves the peptide binding groove". Immunogenetics 44 1 (1996): 19-26. http://www.scopus.com/inward/record.url?eid=2-s2.0-0029936859&partnerID=MN8TOARS.
    10.1007/s002510050085
  322. Mazzocchi, A.; Storkus, W.J.; Traversari, C.; Tarsini, P.; Maeurer, M.J.; Rivoltini, L.; Vegetti, C.; et al. "Multiple Melanoma-Associated Epitopes Recognized by HLA-A3-Restricted CTLs and Shared by Melanomas but Not Melanocytes". Journal of Immunology 157 7 (1996): 3030-3038. http://www.scopus.com/inward/record.url?eid=2-s2.0-0030267510&partnerID=MN8TOARS.
  323. Maeurer MJ; Martin DM; Castelli C; Elder E; Leder G; Storkus WJ; Lotze MT; et al. "Host immune response in renal cell cancer: interleukin-4 (IL-4) and IL-10 mRNA are frequently detected in freshly collected tumor-infiltrating lymphocytes.". Cancer immunology, immunotherapy : CII 41 2 (1995): 111-121. http://europepmc.org/abstract/med/7656270.
    10.1007/s002620050207
  324. Maeurer MJ; Hurd S; Martin DM; Storkus WJ; Lotze MT; Maeurer, M.J.; Hurd, S.; et al. "Cytolytic T-cell clones define HLA-A2-restricted human cutaneous melanoma peptide epitopes: correlation with T-cell receptor usage.". The cancer journal from Scientific American 1 2 (1995): 162-170. http://europepmc.org/abstract/med/9166469.
  325. Castelli, C.; Storkus, W.J.; Maeurer, M.J.; Martin, D.M.; Huang, E.C.; Pramanik, B.N.; Nagabhushan, T.L.; Parmiani, G.; Lotze, M.T.. "Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8+cytotoxic T lymphocytes". Journal of Experimental Medicine 181 1 (1995): 363-368. http://www.scopus.com/inward/record.url?eid=2-s2.0-0028919215&partnerID=MN8TOARS.
    10.1084/jem.181.1.363
  326. Maeurer, M.J.; Martin, D.M.; Storkus, W.J.; Lotze, M.T.. "TCR usage in CTLs recognizing melanoma/melanocyte antigens". Immunology Today 16 12 (1995): 603-604. http://www.scopus.com/inward/record.url?eid=2-s2.0-0029432714&partnerID=MN8TOARS.
    10.1016/0167-5699(95)80084-0
  327. Trinder, P.K.E.; Maeurer, M.J.; Schorlemmer, H.-U.; Loos, M.. "Autoreactivity to mouse C1q in a murine model of SLE". Rheumatology International 15 3 (1995): 117-120. http://www.scopus.com/inward/record.url?eid=2-s2.0-0029113439&partnerID=MN8TOARS.
    10.1007/BF00302128
  328. Maeurer, M.; Zitvogel, L.; Elder, E.; Storkus, W.J.; Lotze, M.T.. "Human intestinal V(d)1+ T cells obtained from patients with colon cancer respond exclusively to SEB but not to SEA". Natural Immunity 14 4 (1995): 188-197. http://www.scopus.com/inward/record.url?eid=2-s2.0-0029554861&partnerID=MN8TOARS.
  329. Storkus, W.J.; Zeh III, H.J.; Maeurer, M.J.; Salter, R.D.; Lotze, M.T.; Storkus WJ; Zeh HJ; et al. "Identification of human melanoma peptides recognized by class I restricted tumor infiltrating T lymphocytes". Journal of Immunology 151 7 (1993): 3719-3727. http://www.scopus.com/inward/record.url?eid=2-s2.0-0027214726&partnerID=MN8TOARS.
  330. Trinder, P.K.; Maeurer, M.J.; Kaul, M.; Petry, E.; Loos, M.; Trinder PK; Maeurer MJ; et al. "Functional domains of the human C1q A-chain.". Behring Institute Mitteilungen 93 (1993): 180-188. http://www.scopus.com/inward/record.url?eid=2-s2.0-0027829162&partnerID=MN8TOARS.
  331. Maeurer, M.J.; Trinder, P.K.; Störkel, S.; Loos, M.; Maeurer MJ; Trinder PK; Störkel S; Loos M. "C1q in autoimmune diseases: rheumatoid arthritis.". Behring Institute Mitteilungen 93 (1993): 262-278. http://www.scopus.com/inward/record.url?eid=2-s2.0-0027791793&partnerID=MN8TOARS.
  332. Maeurer, M.J.; Trinder, P.K.E.; Störkel, S.; Loos, M.. "Modulation of Type II Collagen-Induced Arthritis in DBA/1 Mice by Intravenous Application of a Peptide from the C1q-A Chain". Immunobiology 185 1 (1992): 103-120. http://www.scopus.com/inward/record.url?eid=2-s2.0-0026776430&partnerID=MN8TOARS.
    10.1016/S0171-2985(11)80321-9
  333. Maeurer, M.J.; Trinder, P.K.E.; Loos, M.. "Arthritis-regulating determinants on the collagen-like complement component C1q". Immunology Today 13 7 (1992): 278-279. http://www.scopus.com/inward/record.url?eid=2-s2.0-0026650946&partnerID=MN8TOARS.
    10.1016/0167-5699(92)90011-U
Thesis / Dissertation
  1. Maeurer, Markus. "Funktionelle Stellung der Komplementkomponente Clq beim lokalen Entzu¨ndungsprozess der Rheumatoiden Arthritis". 1991.

Intellectual property

Patent
  1. Maeurer, Markus. 2019. "Vaccines for prevention and treatment of tuberculosis". United States.
    Granted/Issued
  2. Maeurer, Markus; Dodoo, Ernest. 2017. "T-cell receptor sequences for active immunotherapy". Sweden.
  3. Maeurer, Markus; Geyer, J; Dodoo, Ernest. 2017. "Culture medium for cellular immunotherapy". United States.
    Granted/Issued
  4. Maeurer, Markus. 2015. "Expansion of lymphocytes with a cytokine composition for active cellular immunotherapy". United States.
    Granted/Issued
  5. Maeurer, Markus. 2010. "Epitopes and methods to use thereof". United States.
    Granted/Issued

Other

Other output
  1. Increased IL-6 Levels Correlate with Severity of Lung Damage and Early Death in Tanzanian Patients with Pulmonary Tuberculosis. 2018. Nagu, T.; Rao, M.; Aboud, S.; Matee, M.; Fundikira, L.; Nkumbih, Z.; Valentini, D.; et al. http://www.scopus.com/inward/record.url?eid=2-s2.0-85115350678&partnerID=MN8TOARS.
    10.2139/ssrn.3244030
Activities

Oral presentation

Presentation title Event name
Host (Event location)
2019 Immunogenomics and Cancer 5th Workshop on Dendritic Cell Biology
Champalimaud Foundation (Lisbon, Portugal)
2019 Immunotherapy and ocular cancer Ocular oncogenesis and Oncology Conference
Arvo Education (Lisbon, Portugal)

Supervision

Thesis Title
Role 		Degree Subject (Type)
Institution / Organization
2012 - 2017 Immunotherapy for Pancreatic Cancer
Supervisor
 Doctoral (PhD) (PhD)
Karolinska Institutet, Sweden
2012 - 2017 Improving treatment outcomes for patients with pulmonary tuberculosis in Tanzania: Host and Pathogen factors
Supervisor
 Doctoral degree (PhD)
Karolinska Institutet, Sweden
2012 - 2017 MHC class I restricted and antigen-specific TCRs against viral and tumor-associated antigens (TAAs) for future biological therapy
Supervisor
 Doctoral Degree (PhD)
Karolinska Institutet, Sweden
2011 - 2015 Influenza specific T- and B-cell responses in immunosuppressed patients
Co-supervisor
 Doctoral degree (PhD)
Karolinska Institutet, Sweden
2009 - 2013 Specific T- and B-cell Responses against Human Cytomegalovirus after Hematopoietic Stem Cell Transplantation
Co-supervisor
2008 - 2012 Development of MHC class I african alleles and ex vivo detection of M. tuberculosis reactive CD8+ T-cells
Supervisor
 Doctoral Degree (PhD)
Karolinska Institutet, Sweden

Event organisation

Event name
Type of event (Role) 		Institution / Organization
2019 - 2019 Member of the organization and scientific committee of the 7th Annual Immunogenomics Conference (2019 - 2019)
Conference (Member of the Organising Committee)